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ABSTRACT 
 
On Individual and Community-Level Determinants of Pertussis Incidence and 
Vaccination 
 
Neal D. Goldstein 
 
The association between vaccination and vaccine-preventable infectious diseases 
is well established. Vaccines are often highly effective at preventing disease not only in 
an individual, but also in a community. Despite the overall high coverage of vaccination 
in the United States, there has been a recent resurgence of new and existing infectious 
diseases. In particular, incident pertussis (whooping cough) has dramatically increased 
over the last decade, both nationally and locally in Philadelphia, where 2012 saw a 
doubling of the number of cases compared to the prior year. Possible causative agents 
include waning immunity from the Diphtheria, Tetanus, and acellular Pertussis vaccine 
and an increase in vaccination exemptions. This dissertation examined the recent increase 
in pediatric pertussis in Philadelphia through three aims. In the first aim, we examined 
risk factors for pertussis at both individual and contextual (neighborhood) levels, and 
hypothesized neighborhoods with a greater number of day cares would report more cases 
of pertussis. In the second aim, we challenged the traditional notion of vaccination uptake 
defined by the up-to-date status of an individual, and instead propose using the number of 
doses as a better predictor in etiologic analyses. In the third aim, we quantified 
misclassification of pertussis as a result of the changing case definition in 2014 (addition 
of infant apnea) and demonstrated that in vaccine effectiveness studies, the measure of 
association is likely attenuated when the investigator does not re-case classify reported 
cases or consider underreporting of the disease.
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1. BACKGROUND and LITERATURE REVIEW 
1.1. Introduction 
The first vaccination trial occurred over 200 years ago with Edward Jenner 
inoculating subjects with cowpox to protect against smallpox, and since then vaccination 
has been lauded as one of the greatest public health achievements. In the Centers for 
Disease Control and Prevention (CDC) series “Ten Great Public Health Achievements in 
the 20th Century,” immunization was named first in their list of milestones, and few 
would dispute the marked decrease in morbidity and mortality from infectious diseases as 
a result of the development of vaccinations.1,2 
Vaccinations’ effects occur on both the individual and ecological levels: namely, 
conferring individual immunity to a specific pathogen, as well as conferring population 
immunity through herd effect from fewer potential pathogen reservoirs in the community. 
Additionally, there may be group contextual effects, where community characteristics 
influence individual risk profiles for both vaccination receipt and disease occurrence. 
While much work has been done at the individual level, fewer studies have examined the 
ecological, or community, characteristics of both vaccination and vaccine-preventable 
diseases, and even fewer still have considered the multilevel effects. The opportunity 
exists for additional work done at both ecological and mixed levels.  
The importance of vaccination is particularly relevant given the reemergence of 
infectious diseases, like pertussis, that are vaccine-preventable. This trends has spawned 
research at the local, national, and international levels. The Institute of Medicine released 
two reports in 1992 and 2003 addressing emerging infectious diseases, identifying 
constituents at both macro and micro levels.3,4 Of note, the 2003 report explicitly 
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recommended research and development of vaccines to address endemic and emerging 
diseases. The U.S. Department of Health and Human Services’ 2020 Healthy People 
objectives call for continued increased vaccination coverage and reduction in infectious 
disease.5 A task force has also been assembled at the international level, with the World 
Health Organization’s Initiative for Vaccine Research, a previous focus of which was on 
acute respiratory infections.6 Concurrent with these efforts are researcher-led studies to 
address vaccine-preventable infectious disease and vaccination within specific 
communities, the results of which are discussed in the section Characteristics of Disease 
and Vaccination. Due to the continued increase in disease rates and decrease in 
vaccination uptake, work is still needed to identify the specific mechanisms. 
The remainder of this chapter defines terms used throughout this dissertation and 
examines what is known, and the gaps, in current literature about individual, ecological, 
and multilevel characteristics of both vaccination coverage and vaccine-preventable 
disease incidence. Particular attention is given to childhood pertussis (whooping cough) 
as the primary focus of the current research due to its potentially preventable nature and 
public health impact.  
 
1.2. Definitions 
1.2.1. Vaccines and Vaccination 
A vaccine is a substance that triggers an immune reaction in the host without the 
typically deleterious effects of natural infection.7 While in some form or another the 
concept of deliberately inducing immunity in a host has been around for hundreds of 
years, popularization of vaccination is often attributed to Edward Jenner’s smallpox 
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vaccine. A vaccine contains one or more antigens that induce an immune response, and 
can take many forms including live weakened (attenuated) or killed (inactivated) whole 
viruses or bacteria; toxoids produced by the bacteria; proteins or polysaccharides derived 
from the viruses or bacteria; or completely manmade substances such as virus-like 
particles.7 Regardless of the antigen platform, the goal is always the same: to induce 
immunogenicity in the host thereby protecting against wild infection. Vaccination-
induced immunity typically involves both humoral (B-cell) and cellular (T-cell) 
responses and can be active or passive; for the disease of interest in this research active 
immunity in the form of antibody-mediated memory B-cells is of primary concern. 
Vaccination as a public health initiative has a long and, at times, controversial 
past, with conflicting priorities between common welfare and personal liberty (see 
Exempting from Vaccination). While the ideal goal of a vaccination program is to 
eradicate disease, as in the case of smallpox globally, or polio from North America, in 
practice, this may or may not be achievable due to numerous factors.8 Therefore most 
public health initiatives seek to protect populations from disease. A population does not 
require 100% vaccination coverage and immunity to ensure individual protection from a 
disease through a phenomenon known as herd effect/immunity.8 Simply stated, herd 
effect is a threshold level of immunity in the community, where above this level, the 
pathogen’s transmission is effectively blocked. This level varies based on the pathogen’s 
ability to spread and vaccine effectiveness. For example, estimates of vaccination 
coverage to block polio and diphtheria in children range between 80-85% vaccinated, 
while pertussis and measles require much higher 92-95% coverage to achieve herd 
immunity.9 The higher this critical threshold is, the more difficult it becomes to eradicate 
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a disease. Vaccination coverage and adherence to a vaccination schedule are two key 
components for a successful public health program. 
 
1.2.2. Coverage 
Vaccination coverage is a common aggregate measure of individuals vaccinated 
in a community and can represent vaccine program effectiveness. It is assessed by 
examining immunization records at the individual level and characterizing the risk back 
to the population. While an individual can be vaccinated, this does not always confer 
immunity due to a variety of circumstances including genetics, vaccine platform, vaccine 
efficacy and effectiveness, and others.7 Therefore, coverage is a measure of antigen given 
and not necessarily immunogenicity. When the outcome is disease status, a vaccine 
effectiveness study can quantify the reduction of disease in a community through the 
immunization status obtained from the vaccine; that is, how well does the vaccine work 
in the community.10,11 In order to estimate effectiveness, data describing vaccination 
coverage are needed. 
Coverage is defined in several ways, and is dependent on how the individual is 
assessed. A frequently used measure of an individual’s vaccination status is up-to-date 
(UTD). UTD is a dichotomous outcome where an individual, given a specific age, has 
either received all of the recommended doses of one or more vaccines of interest per the 
immunization schedule or has missed one or more doses and is labeled not UTD. 
Another, albeit less frequently used way to define coverage is delayed or age appropriate 
immunization. Delayed immunization implies that one or more doses have not been given 
within the timeframe suggested by the immunization schedule. One study has suggested 
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that delayed immunization may be the more predictive of the two measures for 
enumerating specific risk factors for under immunization.12 These two definitions – UTD 
and delayed immunization – are not mutually exclusive (Figure 1). This research 
considered both definitions of coverage, as well as a raw number of doses given. 
 
1.2.3. Schedules 
The CDC’s Advisory Committee on Immunization Practices (ACIP) publishes 
recommended vaccination schedules endorsed by the American Academy of Pediatrics 
and the American Academy of Family Physicians.13  These schedules are widely used as 
the official timelines for vaccinating children, adolescents, and adults, and most studies 
of vaccination coverage define UTD by these publications. Included in the ACIP 
recommendations are both on-time receipt of vaccination schedules and “catch-up” 
schedules, acknowledging the importance of missed doses and the risk for disease. In 
addition to the CDC/ACIP schedule, there are alternate and reduced vaccine schedules 
that have been proposed and used by a minority of practitioners. The main component of 
these alternate schedules is fewer vaccinations given at a specific visit with more frequent 
visits necessary for the required doses.14,15 The use, safety, and effectiveness of alternate 
vaccine schedules have not been widely studied. The reader is referred to Appendix A: 
Vaccination Schedules for additional information. 
 
1.2.4. Pertussis 
Pertussis, commonly called whooping cough, is the vaccine-preventable 
respiratory infectious diseases of interest in this dissertation. Pertussis is an acute 
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bacterial infection of the respiratory tract caused by the Bordatella pertussis organism. 
This disease is of particular interest as there has been a sharp increase in cases over recent 
years in the United States, shown graphically in Figure 2.16 Figure 2a demonstrates the 
remarkable reduction in disease from the widespread use of the vaccine in the 1940s. Yet, 
focusing on the last few decades, there has been a steady and significant increase in 
nationally reported cases. These increases have not only been attributed to more 
traditional infectious disease risk factors, like secular trends and population crowding, but 
also to a waning immunity effect and more frequent vaccination exemptions.17,18 There 
may be other determinants yet to be elucidated, particularly at the ecological level. For 
example, with the reemergence of certain acute respiratory diseases in the U.S., 
population density and crowding has received particular attention as a possible 
mechanism.4 With more children enrolled in day cares and schools due to shifts in 
parental employment, the number of centers and schools in a community may correlate 
with increased disease in the community.8 
B. pertussis can infect at any age. It is sometimes mistakenly considered a disease 
of childhood, but it can strike adolescents and adults too. Infants and children are 
particularly susceptible to pertussis from not only their immune status, but also the status 
of adolescents and adults who interact with them. Vaccination in adolescents and adults is 
important to protect infants and children, who may be un- or under-immunized. When 
pertussis strikes in childhood, is it particularly severe, and complications include 
pneumonia, encephalopathy, seizures, and sometimes death.19 In fact, among pertussis 
deaths in the U.S., approximately 90% are in infants.20 Therefore, fully understanding the 
epidemiology in childhood is a focus of public health research, including this dissertation. 
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Surveillance for pertussis occurs primarily through passive channels, both in 
Philadelphia and nationally. Pertussis is a notifiable infectious disease; confirmed and 
probable cases require notification to public health authorities. As of 2013, the Council of 
State and Territorial Epidemiologists (CSTE) defines a pertussis case as a cough illness, 
without other apparent causes, lasting at least two weeks, with one or more paroxysms of 
coughing, inspiratory "whoop," or posttussive vomiting.21 During an outbreak, a case 
may be classified as a cough-only illness lasting at least two weeks. If the case is lab-
confirmed or epidemiologically linked to another case, it is deemed confirmed, otherwise 
it is probable. Philadelphia has also recently defined a “suspect” case essentially 
capturing pertussis symptoms without the confirmed two-week cough (PDPH, personal 
communication, November 2013). Local cases are aggregated and sent to the state level, 
which in turn are submitted to the CDC. In Philadelphia, a case is required to be reported 
within five days, and will trigger a subsequent follow up investigation to examine 
vaccination status, exposure history, and relevant clinical data.22 The case report and 
follow-up investigation forms are available in Appendix C: PDPH Notifiable Disease 
Case Report and Appendix D: PDPH Pertussis Investigation Form, respectively. 
Physicians, laboratories, school nurses, day cares, nursing homes, hospitals, state 
institutions, or other locations providing health services must report cases. While the 
passive nature of the system depends on the reporter, due to the severity of illness in 
children, it is hoped that the majority of cases are captured. 
Vaccination for pertussis begins as early as age six weeks, and booster shots are 
recommended throughout adulthood (see Appendix A: Vaccination Schedules). In the 
United States, pertussis vaccination is commonly given with tetanus and diphtheria 
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antigens in a single shot. The formulation for children under age 18 may either be whole 
cell (DTP or DTwP) or acellular (DTaP) given as a five dose series. Licensed in the 
1940s, the whole cell DTP formulation is deactivated B. pertussis organisms and contains 
approximately 3000 antigens. While effective, there were side effect and safety 
concerns.7 This spurred the development of an acellular formulation that contained only 
the core antigens necessary to evoke an immune response. The switch to DTaP in the 
U.S. began in 1992 with the fourth and fifth dose, and all five childhood doses in 1997.17 
However, there appears to be a waning immunity effect associated with the immunity 
conferred from the acellular platform; it may attenuate faster than the whole cell 
platform.17 
 
1.2.5. Exempting from Vaccination 
Vaccination is often a mandated public health initiative, with schools, employers, 
and other entities requiring proof of, or exemption from, vaccination. Exemption can take 
a variety of forms including medical, ideological, philosophical, and religious reasons. 
The specific exemptions allowed vary on a state-by-state basis. For a more detailed 
discussion, refer to Appendix B: Vaccination Exemptions. 
Consequences for exempting vaccination in otherwise indicated children could 
lead to increased preventable morbidity and mortality. There have been outbreaks of 
measles in both the U.S. and the U.K. connected to parents exempting their children from 
the MMR vaccine.23,24 A recent study of clustered pertussis cases in California found 
significant increases in community rates of disease for clusters that had a higher 
proportion of non-medically exempted children.18 Similar results were documented in 
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Colorado for both measles and pertussis exemptors.25 In their urgently entitled 
perspective piece “Go Big and Go Fast – Vaccine Refusal and Disease Eradication,” 
Omer and other key opinion leaders in the vaccine community noted that exempting from 
vaccination “threatens [the diseases’] regional elimination and eventual global 
eradication.”26 Describing characteristics of vaccination acceptance and adherence, and 
the impact this has on the public’s health is important because health officials can use this 
information to ensure the at-risk populations are identified. It is also important for 
practitioners to be cognizant of a wide spectrum of individual beliefs. 
 
1.3. Characteristics of Disease and Vaccination 
An existing body of literature exists that identifies risk factors and correlates of 
infectious disease incidence and vaccination uptake. Most studies examine individual 
level exposures and outcomes, retrospectively. A smaller subset of studies considers 
group determinants, and an even smaller set model both individual and group 
determinants in relation to infectious disease. For clarity, these individual and group 
characteristics can be partitioned into four categories: 1) demographic, 2) socioeconomic, 
3) medical, and 4) immunization. Although there may be some overlap, it is instructive to 
consider these characteristics within categories, as some factors are immutable (certain 
demographics and medical conditions), some factors are changeable, but difficult 
(socioeconomic), while others are more readily changed and influenced by public health 
(immunization). When possible, studies specific to infectious respiratory diseases and 
vaccinations were referenced, although in ecologic and multilevel analyses, the small 
number warranted broadening the search to other infectious diseases with similar risk 
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factors (e.g., pneumonia). Additionally, studies based in the U.S. were given priority. 
When no U.S. study was available, research conducted outside the U.S. was included. 
Due to the wide variety of study populations, designs, and analyses, summary measures 
of association were not calculated. Table 1 summarizes the reviewed studies. 
 
1.3.1. Individual 
Thirty-eight individual level infectious disease and vaccination studies were 
identified in the literature search and subsequently reviewed. This section summarizes the 
consistent characteristics of disease occurrence and vaccination uptake for these studies. 
 
Demographic 
Younger age was consistently associated with infectious disease in many 
studies.36,37,38,40,41,43,44,45,46,47,50 As increase in child’s age is strongly associated with 
vaccination receipt this may be a confounding effect of vaccination, although many 
studies did control for immunization history. Minority race and Hispanic ethnicity were 
also found predictive of disease and possibly indicate access to preventive care or 
socioeconomic status (SES) disparities.41,47,51 Studies that examined an independent 
sex/gender effect were mixed in the direction and significance of their 
results.39,40,42,45,48,50,52 This could represent stress or behavioral differences, which may 
weaken the immune system leaving one more susceptible to infection,50 as well as a 
biologic susceptibility whereby hormones may interact with the immune system leaving 
females more vulnerable to certain diseases based on their age.27 Turning to 
immunization status, race, ethnicity, older age, sex/gender, nativity, marital status, and 
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parental cohabitation were positively associated with 
immunizations.12,63,64,65,67,68,71,73,76,78,79,81 Despite these positive associations with 
immunization, inconsistencies across studies make it difficult to summarize the effects. 
 
Socioeconomic 
Socioeconomic indicators were more varied in their definitions, but consistent 
themes arose. When the child attended day care or school, had close contact with others, 
lacked insurance, and lived in a low SES class, there was an increased risk of acquiring 
disease.38,39,43,45,49,52 Increased maternal education and living in a two-parent household 
reduced the risk of disease.38,43,52 These findings suggest that communicable diseases are 
readily spread through close proximity to other infected individuals, who are more likely 
in lower SES classes due to household size and crowding. Significant predictors of 
immunization included increased education, employment, health insurance, population 
density and urban dwelling, and SES.12,63,64,65,66,67,73,76,79,80,81 Population density and urban 
dwelling were found to be both positive and negative predictors of vaccination, which 
could potentially be explained by access to care and/or effect modification by community 
SES. Household characteristics of vaccination receipt included mother/father 
cohabitation and birth order/number of children.12,63,65,66,75,79 Later birth order (or 
increased number of children) was associated with missed vaccination.  
 
Medical 
Comorbidities, pregnancy, and delayed treatment were associated with increased 
pertussis severity.36,46,49,50 A normal birth weight, breastfeeding, and prenatal care 
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increased the likelihood of pertussis vaccination.63,65,66 Engaging in health-seeking 
behaviors potentially explains these associations. 
 
Vaccination 
Vaccination status was positively associated with disease in numerous 
studies.38,40,42,44,48,49  Delayed or early immunization was also positively associated with 
disease, indicating that on-time receipt of the correct dose is important for establishing 
immunity in multi-dose series.43,44,48 Time since last dose (i.e., waning immunity) was 
predictive of pertussis in only one study, despite several considering this variable.17  
Existing studies have identified personal beliefs, delayed or early immunization, provider 
vaccinating, and provider administering multiple vaccines at the same visit as factors 
associated with higher coverage.12,63,64,67,69,70,72,74,77,80,81 Access to care probably explains 
several of these findings, and while it is hypothesized to be an important factor, there is 
little existing research specific to access to vaccination and its effects on coverage. 
Contradicting with the so-called alternate vaccinate schedules, not administering multiple 
vaccines at the same office visit was associated with lower vaccination up-to-date rates. 
This finding potentially argues against having more office visits with fewer shots, a key 
component of the alternate schedules. 
 
1.3.2. Ecological 
Ecological studies evaluate associations at the aggregate, or community level. For 
example, an ecological study may measure an aggregate indicator of neighborhood 
income and percent diseased, while an individual study may measure individual incomes 
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and disease status. Both studies could have completely different findings, and inferring 
findings between levels could result in an ecologic or atomistic fallacy, where a 
significant result at one level cannot be inferred to the other level. Additionally, 
aggregate measures can reflect constructs at multiple geographic scales, for example, 
country level vaccination coverage versus neighborhood level coverage. This potentially 
makes comparing ecological studies problematic; therefore this review does not provide 
summary measures of association but reports only consistent themes in the literature for 
the purposes of risk factor and potential confounder selection. Seventeen ecological level 
infectious disease and vaccination studies were identified in the literature search and 
subsequently reviewed. This section summarizes the consistent characteristics of disease 
occurrence and vaccination uptake for these studies. 
 
Demographic 
Younger average age, minority race, Hispanic ethnicity and nativity55,57,58 were 
positively associated with community disease, while nativity and higher percentage of 
single parents were negatively associated with vaccination coverage.82,84,86 These 
measures may be describing an SES effect, where minority populations live in more 
impoverished areas with overall poorer health. Ruijs et al. specifically examined religion 
as a predictor of vaccination coverage, as they had a priori evidence that certain 
denominations were less likely to immunize, and found a positive association.86 Teasing 
out this correlation in other populations will require the same a priori evidence that 
certain religious groups in a given area are less likely to vaccinate. 
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Socioeconomic  
Community SES, measured in various ways including education, employment, 
income, or health expenditure, associated with disease varied in terms of direction of the 
association.18,53,55,56,59,60,61 The lack of consistency may be an ecological effect, as lower 
individual SES is well known to be correlated with disease, or an artifact of the study 
design. Community measures of built environment, including mobility (also defined as 
migration or community stability), public transportation use, and lack of communication 
infrastructure were significant predictors of disease in several studies.54,55,57,58 Chan et al. 
measured communication infrastructure by telephone line density and hypothesized that a 
community with better flow of information (i.e. higher telephone line density) can better 
deal with public health threats, potentially contrary to the urban crowding belief that 
close proximity to others spreads disease. Measures of lower SES (education, 
employment, income) and population density/urban environment were important 
predictors of vaccination coverage.82,83,84,85,86,87 As with the individual analysis, 
population density and urban dwelling varied in the direction of association. Again, 
access to care and SES could be the key drivers in understanding the complex relation 
between vaccination coverage and disease occurrence.  
 
Medical 
Aggregate measures of comorbidities and lack of access to treatment, were 
correlated with increased respiratory infectious diseases in two ecological studies.56,58 
This may reflect overall health of the community, both figuratively (i.e., community 
deprivation) and literally. 
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Vaccination 
Most notable of the ecological immunization factors is the concept of herd 
immunity (also expressed as percent vaccinated in a community; see Vaccines and 
Vaccination). Herd effect was associated with a statistically significant reduction in 
disease occurrence and underscores the importance of immunizing a large proportion of 
the population to control disease.9,54,55 Similar to the individual level studies, both 
aggregate measures of delayed immunization and provider/location of vaccination (e.g., 
primary care physician, school vaccination clinic) were important predictors of 
community vaccination coverage.83,84 
 
1.3.3. Multilevel 
Multilevel studies are relatively infrequent in infectious disease epidemiology, 
especially when examining vaccination and vaccine preventable diseases.28 This review 
identified and reviewed four such studies. Unlike pure ecological studies, which solely 
examine the exposure/outcome relation at the population level, and individual studies, 
which solely examine the exposure/outcome relation at the subject level, multilevel 
studies allow for clustering of individuals within a group to examine the 
exposure/outcome relationship simultaneously at the both levels. In other words, the 
exposure/outcome relationship can vary with respect to the contextual differences of the 
community where one resides.29 This analytic method is particularly useful for answering 
etiologic questions like “Are there significant neighborhood differences in infectious 
disease etiology after considering individual effects?” and “Are there significant 
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individual differences in infectious disease etiology after considering neighborhood 
effects?” Additionally, these studies can assess interactions between the two levels: “Do 
neighborhood characteristics of infectious disease modify individual risk?”  
Failure to consider multilevel effects can lead to erroneous conclusions.28 In 
particular, an individual-level study elucidating vaccination uptake characteristics 
inferred to group vaccination determinants may be subject to the atomistic fallacy. For 
example, in a study of pneumococcal vaccination uptake in a long term care facility, 
Bardenheier et al. demonstrated that using only an individual level analysis may result in 
Type I errors (i.e., a false positive) as the random effects of the long term care facilities 
are not considered.88 Specifically, one such false positive was found for the demographic 
variable race. In an individual level analysis it was an important predictor of vaccine 
receipt, while in the multilevel analysis race was a correlate of the populations in the long 
term care facility and not an important predictor on its own. In short, it was not one’s race 
that accounted for vaccination status but living in specific facility that was key. Therefore 
in clustered data, multilevel analysis considers not only resident (individual level) 
characteristics of vaccine uptake, but also facility (group level) characteristics, which is 
important because quality of care may differ between nursing homes. A similar analysis 
by Jones et al. in the U.K. concluded that pertussis vaccination receipt was a factor of 
both “who you are,” that is individual sociodemographic characteristics, and “where you 
go,” the clustered practice characteristics, such as the location of the practice.89 A 
vaccination coverage study in northern Nigeria also reached the same conclusion on the 
importance of considering multiple levels in analysis: namely, individual, household, and 
community.90 Lowcock et al. demonstrated neighborhood deprivation (an index measure 
	  	  
 
17	  
consisting of material and social deprivation) was a contextual risk factor for pandemic 
H1N1 influenza independent of individual risk factors, such as education, and additional 
contextual differences may yet be revealed.62 These few examples demonstrate the 
importance of considering the contextual features of the group levels, and therefore a 
major focus of this research will be the use of multilevel analysis. 
Despite multilevel analysis considering both individual and ecological effects, 
care needs to be given to guard against ecological fallacy. The ecological fallacy has been 
well known in research since Robinson articulated it mathematically in his 1950 seminal 
paper.30 Simply stated, ecologic fallacy is incorrectly inferring individual effects from 
group effects. For example, suppose an ecological study found a positive association 
between percent vaccinated and percent diseased at the neighborhood level. Further 
suppose that vaccinated individuals lived in neighborhoods with more endemic disease. 
Inferring that individuals who are vaccinated are more likely to get disease would be 
incorrect, as this was merely an artifact of vaccinated individuals living in neighborhoods 
with much higher rates of disease (presumably among the few unvaccinated individuals). 
Multilevel analysis offers tighter control over introducing this mistake.31 Continuing with 
the previous example, controlling for this neighborhood rate of endemic disease should 
yield the true relationship between an individual’s vaccination status and disease 
occurrence.  
 
1.3.5. Summary of Characteristics 
Demographic, socioeconomic, medical, and immunization characteristics were 
identified as risk factors for disease and incomplete vaccination on the individual level. 
	  	  
 
18	  
Maternal and family dynamics were particularly important predictors, and seemed to 
suggest that traditional health seeking behaviors were correlated with increased 
vaccination coverage and lower disease incidence. Various socioeconomic indicators 
were strongly associated with disease and immunization; enumerating these 
characteristics can help target initiatives to the right population. Measures of group SES 
and demographics were the most consistent factors associated with disease occurrence 
and vaccination coverage at the ecological level. Herd immunity was a key predictor of 
community disease, and reduced barriers to access care at the community level (namely 
the provider/location of vaccination) was positively associated with vaccination coverage.  
The studies in this literature review varied greatly in terms of the populations and 
characteristics enumerated. Each study used metrics that were readily accessible in that 
population. While Philadelphia was not explicitly studied in the reviewed literature, the 
characteristics of disease and vaccination at an individual level should hold in this 
population. At the aggregate level, the heterogeneous communities of the city may not be 
accurately reflected by existing literature. Compared to other cities in Pennsylvania, 
Philadelphia has been ranked last among key health outcomes, as well as ranking behind 
national benchmarks, potentially affecting generalizability of other studies to 
Philadelphia problematic.32 Although the dynamics of infectious disease may not differ 
biologically, health and health care disparities in Philadelphia are likely driving the main 
differences, and these should be made as explicit as possible to guide public health policy 
and programs. The following conceptual diagram depicts the hypothesized complex 
interplay between the characteristics of disease and vaccination at an individual and 
ecological level (Figure 3). 
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1.5. Theoretical Framework 
While the focus of this research was not framework theory, it was still instructive 
to use a formal framework to guide population and variable selection. The Health Belief 
Model (HBM) is particularly useful in vaccine research.26 Quoting Glanz et al., “[t]he 
HBM theorizes that people’s beliefs about whether they are at risk for a disease or health 
problem, and their perceptions of the benefits of taking action to avoid it, influence their 
readiness to take action.”33 In other words, for an individual to take preventive action for 
a disease, he or she internally assesses the pros and cons of receipt of vaccine in the 
context of the personal (ideological, philosophical, religious, etc.) beliefs held. The HBM 
is one of the most often used and widely recognized models in the health behavior field.33 
Applying the core constructs of this model yields several general categories of variables 
that should be considered in vaccine research (Table 2). 
 
1.6. Specific Aims and Dissertation Organization 
This research examined how an individual risk factors for an acute respiratory 
infectious disease were influenced by group characteristics and by vaccination uptake, 
represented diagrammatically in Figure 3. Three facets of this model included: 1) 
searching for an etiologic cause of the recent increase in pertussis in Philadelphia, 2) 
examining the best measure of vaccine uptake to explain this increase, and 3) assessing 
possible bias introduced by changing pertussis case definitions. 
The recent rise in pertussis in the U.S. has been attributed to a waning DTaP 
immunity and an increase in vaccination exemptions. In both cases, this potentially 
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increases the number of susceptible individuals in the community, the number of 
subclinical cases, and consequently opportunities for disease transmission and infection 
in children. While individual risk factors for pertussis have been enumerated, less work 
has been done at the population level, and there may be contextual differences whereby 
an individual’s risk for pertussis is different based on the characteristics of the 
community he or she lives in. For example, it is well known that not getting vaccinated 
can lead to disease, but getting vaccinated may depend on your social class. Philadelphia 
has experienced a similar increase in pertussis cases as the U.S., and in fact had more 
than a twofold increase in reported cases in 2012 compared to any year in the previous 
decade.34 We quantified the recent increase in cases in Philadelphia, identified the 
individual and community determinants of disease, and assessed whether group 
characteristics (i.e., density of day cares) affected individual disease. This work was 
innovative because use of multilevel modeling in infectious diseases was limited, 
specifically with respect to vaccine-preventable diseases. 
In addition, this research compared the usefulness of three different measures of 
vaccination uptake (coverage) in predicting the risk of pertussis. We compared up-to-date 
(UTD), the most common measure; delayed immunization, a less common measure; and 
a raw count of the number of doses of vaccine. Evaluating several measures of pertussis 
vaccination uptake was especially important as there are five doses recommended in 
childhood, and simply stating whether a child is UTD may not have accounted for delays 
in getting vaccinated. This potentially left the child vulnerable during the delayed period. 
Prior research suggested that delayed immunization may in fact be the more useful 
measure for predicting risk, but its use in disease etiology studies was limited. We 
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compared these measures in the pertussis population in Philadelphia to determine 
whether delayed immunization was the more important predictor of disease. 
Last, we quantified bias potentially introduced by the changing case definition of 
pertussis. Since the switch to DTaP began in 1997 to present, the case definition has 
changed two times, with the most recent change in 2014. As the current case definition is 
applied at the time a potential case develops, this translates into cases captured according 
to varying definitions over time. Consequently retrospective studies utilizing historic data 
may have changing case definitions, depending on the time periods considered. By case 
classifying the historic data according to the changing definitions, we quantified the 
amount of misclassification bias introduced in the association between vaccination and 
pertussis. 
The Philadelphia Department of Public Health (PDPH) Division of Disease 
Control conducts active and passive surveillance for infectious diseases citywide. 
Vaccination records are required to be reported to the city’s immunization information 
system, KIDS Plus IIS.35 KIDS Plus IIS provides a lifetime snapshot of immunization 
history, is linked to a variety of other systems including vital records to provide other 
health related data, and serves the entire Philadelphia area for residents of all ages. Using 
data from these systems, we estimated disease occurrence, vaccination coverage, and the 
relationship between the two to answer these questions: 
1. What was the baseline community rate of vaccination and disease, and how did 
this change over time? Did children in day cares affect the base risk of disease in 
a community? 
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2. Should future research assess delayed immunization over UTD or number of 
doses as the more predictive metric of vaccination uptake for pertussis? 
3. Should retrospective studies reclassify pertussis status according to current or 
historic case definitions, or leave pertussis status as-is? 
 
The remainder of this dissertation is organized into chapters relevant to the following 
specific aims: 
Chapter 2. Aim #1: Identify group differences in pertussis risk in Philadelphia 
controlling for individual factors, and assess whether density of day cares affects 
individuals’ risk. 
Hypothesis 1. The density of day cares in an area is positively associated 
with incidence of childhood pertussis infection in Philadelphia, controlling 
for individual and community characteristics.  
Chapter 3. Aim #2: Evaluate three measures of vaccine uptake (i.e., UTD, delayed, 
number of doses) and their relationship to pertussis incidence. 
Hypothesis 2. Delayed immunization is a superior measure for vaccination 
coverage in a vaccine effectiveness study compared to up-to-date and 
number of doses. 
Chapter 4. Aim #3: Quantify the information bias present in retrospective, historic 
vaccine effectiveness studies by misclassification of the outcome, pertussis. 
Hypothesis 3. Case classifying according to the 2014 case definition of 
pertussis (addition of infant apnea) minimizes information bias. 
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Chapter 5. Summarizes the findings of this research, enumerates the strengths, 
acknowledges the limitations, and frames the work in the greater body of public 
health knowledge. 
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1.7. Tables and Figures 
Table 1. Characteristics of disease and vaccination by study type, analysis level, 
author, year, country, and primary infectious disease(s). 
Author, Yearref. Country Disease(s)* Statistically significant risk factors 
Disease Occurrence 
 Individual 
  Bagdure et al., 
201036 
U.S. Pandemic 
H1N1 influenza 
Age, Comorbidities 
  Biellik et al., 
198837 
U.S. Pertussis Age 
  Bisgard et al., 
200538 
U.S. Pertussis Maternal age†, Maternal education†, Insurance 
status, Attended day care/contact at school, 
Crowding/close contact, Vaccination status 
  Brennan et al., 
200039 
U.S. Pertussis Sex/gender, Crowding/close contact 
  Briand et al., 
200740 
France Pertussis Age, Vaccination status 
  CDC, 2009b41 U.S. Pandemic 
H1N1 influenza 
Age, Race, Ethnicity 
  Farizo et al., 
199242 
U.S. Pertussis Vaccination status 
  Grant et al., 
200343 
New 
Zealand 
Pertussis Age, Maternal education†, Income/poverty/SES, 
Crowding/close contact, Delayed or early 
immunization 
  Halperin et al., 
199944 
Canada Pertussis Age, Vaccination status, Delayed or early 
immunization 
  Izurieta et al., 
199645 
U.S. Pertussis Maternal age†, Insurance status, Visiting other 
household 
  Jhung et al., 
201146 
U.S. Pandemic 
H1N1 influenza 
Age, Comorbidities, Pregnant 
  Kenyon et al., 
200647 
U.S. Pertussis Age, Ethnicity 
  Khan et al., 
200648 
U.S. Pertussis Vaccination status, Delayed or early 
immunization 
  Khetsuriani et 
al., 200149 
U.S. Pertussis Crowding/close contact, Delayed treatment, 
Vaccination status 
  Klein et al., 
201050 
U.S. Pandemic 
H1N1 influenza 
Age, Sex/gender, Employment/occupation, 
Comorbidities, Pregnant 
  Tanaka et al, 
200351 
U.S. Pertussis Ethnicity 
  Tartof et al., 
201317 
U.S. Pertussis Time since last dose/waning immunity 
  Thrane et al., 
200552 
Denmark Respiratory 
infectious 
disease 
Parental cohabitation†, Maternal education†, 
Income/poverty/SES 
 Ecological 
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Author, Yearref. Country Disease(s)* Statistically significant risk factors 
  Anderson et al., 
19909 
U.S. Pertussis Immunization coverage/herd effect 
  Atwell et al., 
201318 
U.S. Pertussis Race, Family size, Education, 
Income/poverty/SES, Population density/urban 
dwelling, Immunization exemption/personal 
belief 
  Bonds et al., 
201053 
Various Various Income/poverty/SES, Fertility/birth rate 
  Chan et al., 
201354 
Various Various Communication infrastructure, Immunization 
coverage/herd effect 
  Emch et al., 
200655 
Bangladesh Cholera Age, Employment/occupation, 
Mobility/migration, Immunization 
coverage/herd effect 
  Haroon et al., 
201156 
U.K. Pandemic 
H1N1 influenza 
Race, Income/poverty/SES, Access to treatment 
  Maliszewski et 
al., 201157 
U.S. Pandemic 
H1N1 influenza 
Age, Public transportation 
  Murray et al., 
201158 
Various Tuberculosis Age, Mobility/migration, Crowding/close 
contact, Comorbidities 
  Myers et al., 
200659 
U.S. Tuberculosis Race, Ethnicity, Foreign born/nativity, 
Income/poverty/SES 
  Nikolopoulos et 
al., 201160 
Various Pandemic 
H1N1 influenza 
Health expenditure 
  Siegel et al., 
199761 
U.S. Pertussis Ethnicity, Income/poverty/SES 
 Multilevel 
  Lowcock et al., 
201262 
Canada Pandemic 
H1N1 influenza 
Education (individual), Material deprivation 
(group) 
Vaccine Uptake 
 Individual 
  Bates et al., 
199863 
U.S. DTP, Polio, 
MMR 
Maternal age†, Race, Maternal marital status†, 
Maternal education†, Insurance status, 
Income/poverty/SES, Birth order/children in 
household, Prenatal care†, Delayed or early 
immunization, Provider vaccinating/location 
  Bish et al., 
201164 
Various Pandemic 
H1N1 influenza 
Age, Sex/gender, Ethnicity, Education, 
Employment/occupation, Immunization 
exemption/personal belief, Provider 
vaccinating/location 
  Bobo et al., 
199365 
U.S. DTP, Polio Maternal marital status†, Maternal education†, 
Birth order/children in household, Birth weight 
  Brenner et al., 
200166 
U.S. DTP, Polio, Hib Maternal employment†, Income/poverty/SES, 
Birth order/children in household, Breastfed† 
  Brien et al., 
2012b67 
Various Pandemic 
H1N1 influenza 
Age, Sex/gender, Education, 
Employment/occupation, Immunization 
exemption/personal belief, Provider 
vaccinating/location 
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Author, Yearref. Country Disease(s)* Statistically significant risk factors 
  CDC, 2009a68 U.S. DTP, MMR, 
HBV, Varicella, 
MCV, HPV 
Race, Ethnicity, Income/poverty/SES 
  Dombkowski et 
al., 200412 
U.S. DTP, Polio, 
MMR 
Sex/gender, Race, Parental cohabitation†, 
Maternal education†, Insurance status, 
Population density/urban dwelling, Birth 
order/children in household, Provider 
vaccinating/location 
  Gomez et al., 
201269 
U.S. Pandemic 
H1N1 influenza 
Comorbidities, Immunization 
exemption/personal belief 
  Hilyard et al., 
201370 
U.S. Pandemic 
H1N1 influenza 
Comorbidities, Provider vaccinating/location 
  Kansagra et al., 
201471 
U.S. Pandemic 
H1N1 influenza 
Age, Sex/gender, Vaccination status 
  Koepke et al., 
200172 
U.S. DTP, Polio, 
MMR, Hib, 
HBV 
Provider vaccinating/location 
  Lu et al., 201373 U.S. Seasonal 
influenza 
Age, Race, Ethnicity, Employment/occupation, 
Comorbidities, Availability of vaccine 
  Meszaros et al., 
199674 
U.S. Pertussis Immunization exemption/personal belief 
  Reading et al., 
200475 
U.K. Pertussis, MMR Birth order/children in household 
  Sakou et al., 
201176 
Greece DTP, Polio, 
HBV, HAV, 
MMR MCV 
Age, Sex/gender, Foreign born/nativity, 
Population density/urban dwelling 
  Tickner et al., 
201077 
U.K. DTP, Polio, 
MMR 
Immunization exemption/personal belief 
  Trauth et al., 
200278 
U.S. DTP, Polio, 
MMR 
Race, Birth order/children in household 
  Vandermeulen 
et al., 200879 
Belgium MMR, HBV, 
MCV 
Parental cohabitation†, Maternal employment†, 
Birth order/children in household 
  Williams et al., 
199480 
U.S. DTP, Polio, 
MMR 
Population density/urban dwelling, Delayed or 
early immunization, Provider administers 
multiple vaccines 
  Williams et al., 
199581 
U.S. DTP, Polio, 
MMR 
Age, Income/poverty/SES, Population 
density/urban dwelling, Delayed or early 
immunization, Provider administers multiple 
vaccines 
 Ecological 
  Brien et al., 
2012a82 
Canada Pandemic 
H1N1 influenza 
Foreign born/nativity, Income/poverty/SES 
  Davila-Payan et 
al., 201483 
U.S. Pandemic 
H1N1 influenza 
Income/poverty/SES, Provider 
vaccinating/location, Availability of vaccine 
  Hull et al., 
200184 
Australia DTP, MMR Foreign born/nativity, Single parents, Education, 
Employment/occupation, Delayed or early 
immunization, Provider vaccinating/location 
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Author, Yearref. Country Disease(s)* Statistically significant risk factors 
  Narciso et al., 
201285 
U.S. Pandemic 
H1N1 influenza 
Income/poverty/SES 
  Ruijs et al., 
201186 
Netherlands DTP, Polio Foreign born/nativity, Religion, 
Income/poverty/SES, Population density/urban 
dwelling 
  Wright et al., 
200687 
U.K. MMR Education, Income/poverty/SES, Population 
density/urban dwelling 
 Multilevel 
  Bardenheier et 
al., 200588 
U.S. PCV Standing order (group), Business type (group), 
Unstable health (individual), Length of stay 
(individual) 
  Jones et al., 
199189 
U.K. Pertussis Sociodemographic characteristics (individual), 
Location of practice (group) 
  Babalola, 
200990 
Nigeria DTP Place of birth (individual), Immunization 
documentation (individual), Mother’s beliefs 
(individual), Social approval (group) 
* DTP = Diphtheria, Tetatnus, Pertussis; MMR = Measles, Mumps, Rubella; HBV = Hepatitis B virus; 
HCV = Hepatitis C virus; Hib = Haemophilus influenzae type b virus; MCV = Meningococcus serogroup 
C virus; HPV = Human papillomavirus; PCV = Streptococcus pneumonia virus. 
† Parental characteristics are given when the study population included children. 
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Table 2. Constructs of the Health Belief Model and example variable selection. 
Construct Example Variables 
Perceived Susceptibility Population density/urban dwelling, Comorbidities 
Perceived Severity Disease prevalence and incidence 
Perceived Benefits Age, Education, Pregnant, Birth order/children in household 
Perceived Barriers Income/poverty/SES, Insurance status 
Cues to Action Provider vaccinating/location 
Self-Efficacy Immunization exemption/personal belief 
Adapted from Glanz et al., 201033 
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Figure 1. Hypothetical DTaP statuses evaluated per 2013 CDC/ACIP birth-18yo 
schedule. 
 
UTD, Up-to-date. 
  
	  	  
 
30	  
Figure 2. Pertussis cases in the US: 1922-2012 (a.) and 1990-2012 (b.). 
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Figure 3. Overarching conceptual diagram. 
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2. DENSITY of DAY CARES in RELATION to REPORTED PERTUSSIS 
INCIDENCE in PHILADELPHIA, 2001 – 2013 
 
 
2.1. Abstract 
Background: Reported pertussis incidence has increased markedly in Philadelphia 
between 2001 and 2013. The increase may be related to the more frequent use of 
childcare services by parents over the last few decades. Additionally, clustering of 
outbreaks may be related to neighborhood characteristics not previously identified. 
Methods: We conducted a city-wide case-control study of children in Philadelphia aged 
birth through six years, between 2001 and 2013. Multilevel logistic regression was used 
to isolate the independent contributions of individual and neighborhood risk factors and 
the corresponding relative odds of pertussis. Vaccination was examined at both the 
invidual level (up-to-date on pertussis-antigen contained vaccines) and neighborhood 
(percent up-to-date). The density of day cares in each neighborhood served as the main 
exposure and reported incident cases of confirmed and probable pertussis was the main 
outcome. 
Results: Two thousand fifty children aged birth through six years from 45 Philadelphia 
neighborhoods were eligible for inclusion. There were 410 cases of confirmed and 
probable pertussis among these children between 2001 and 2013. There was a 30% 
increase in the risk of pertussis based solely on the neighborhood where the children 
resided (median odds ratio 1.3, 95% credible interval 1.1, 1.6). The density of day cares 
in each neighborhood was unrelated to the distribution of pertussis cases. 
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Conclusion: Pertussis clustering was observed at the neighborhood level in Philadelphia. 
From a Health Department perspective, the highest risk neighborhoods should be targeted 
for vaccine campaigns and further research to identify the etiologic risk factors. 
 
2.2. Introduction 
Effective pathogen transmission is dependent on a variety of host, agent, and 
environment characteristics: the epidemiological triad. One of the most well known 
correlates of infectious disease transmission is close contact of at-risk individuals. For 
vaccine preventable diseases, like pertussis, at risk can mean un- or under-vaccinated. 
With the right conditions, congregation of at-risk individuals could provide an opportune 
breeding ground for disease. Day cares provide this opportune congregation of children 
and adults.  
With parental shifts in employment over the last few decades, day care enrollment 
as well as the number of facility options in a community have both increased, and thus 
the recent increase in respiratory infectious diseases may be partially attributable to this 
occurrence.8 A review of vaccine-preventable infectious diseases in day cares noted that 
the average age of children enrolled in day care was decreasing, while immunization 
coverage was increasing.91 Further for multi-dose vaccination series, like pertussis, the 
overall younger age means more children with potentially vulnerable immune statuses, as 
the full series has not been completed. To demonstrate a correlation between day care use 
and community infection, the key assumption is that the community uses local day care. 
A 2013 review of child care decision making processes noted both “accessibility of 
providers is […] a strong correlate of child care choices” and travel beyond the local 
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community for day care was often “unmanageable,” particularly for low income 
families.92 
Few studies have been conducted that consider day care attendance as the primary 
exposure and pertussis as the outcome. This disease is of particular interest as there has 
been a sharp increase in cases over recent years, both locally and nationally.34 Two 
studies conducted in Israel in the 2000s found evidence that pertussis outbreaks can occur 
in these congregant settings despite high vaccination coverage, and further that 
vaccinated children can be asymptomatic carries of the pathogen.93,94 This underscores 
the importance of not only proper vaccination for children and adults within the day care 
environment, but also protection for the community at large as these children interact 
within their built environment. As the crowding conditions in the built environment 
increase, the risk for disease may also increase. We sought to examine the interplay 
between Philadelphia neighborhood and pertussis risk, with specific focus on day cares as 
the risk factor of interest. 
 
2.3. Methods 
2.3.1. Source Population and Study Sample 
The source population for this study was children who were registered in KIDS 
Plus, the city’s immunization information system (IIS). The KIDS Plus IIS represents an 
open cohort of children who were born in Philadelphia or received vaccinations from 
Philadelphia-based providers and it was used to derive the study sample of both incident 
pertussis cases and controls for a nested case-control analysis. Potential pertussis cases 
were reported to the Philadelphia Department of Public Health (PDPH) as mandated by 
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the Philadelphia Health Code.22 Controls were selected using incidence density sampling 
from non-case children in KIDS Plus IIS at a 4:1 control to case ratio and frequency 
matched by date of birth to within two weeks. When a potential case occurred in an infant 
less than two weeks of age, the control had to be born before the case diagnosis date to 
ensure the control was eligible to become a case at the time of diagnosis. The study 
sample was restricted to children born between 1-Jan-2001 and 31-Dec-2013, and only 
included children aged birth through six years to capture the full five-dose series of 
pertussis vaccine in childhood. Given the very high pediatric vaccination rates in 
Philadelphia, children with fewer than two vaccines (any type) were excluded as these 
children were considered born in Philadelphia but moved or resided elsewhere. Only 
cases and controls that had geocodable addresses were included due to the multilevel 
modeling requirements. Geocoding was performed using Google Map’s Application 
Program Interface using freely available R code.95 This study was approved by the 
Institutional Review Boards for the City of Philadelphia and Drexel University 
(Philadelphia, PA). 
 
2.3.2. Exposure, Outcome, and Covariates 
The primary exposure for this study was the number of day cares in a 
neighborhood. The Pennsylvania Department of Public Welfare (DPW) tracks day cares 
statewide and classifies them into three categories based on the number of enrolled 
children (Table 3).96 A fourth category of day cares not captured by the DPW, but known 
to exist, represents the greatest potential for bias if more pertussis cases occur in these 
locations. There were approximately 2000 registered day cares in Philadelphia at study 
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time: 900 child care centers, 200 group child care homes, and 900 family child care 
homes.  
The day care variable was operationalized into several competing measures that 
conceptually represent different neighborhood features and the most parsimonious 
predictor assessed by comparing AIC/BIC was ultimately modeled in the statistical 
analysis. First, we examined a raw count of the number of day cares in each 
neighborhood. Next, we adjusted this count by dividing by the area of the neighborhood 
(in square miles) creating a day care density measure representing the ease of accessing 
the resource. Third, we adjusted the raw count by the number of children under age five 
in each neighborhood creating a day care per capita measure representing the availability 
of the resource. Finally, we divided the per capita measure by the area of the 
neighborhood (in square miles) creating a day care per capita density variable 
representing both ease of accessing and availability of the resource. 
The outcome under study was reported incident cases of confirmed or probable 
pertussis, defined by the Council of State and Territorial Epidemiologists (CSTE) as a 
cough illness, without other apparent causes, lasting at least two weeks, with one or more 
paroxysms of coughing, inspiratory "whoop," or posttussive vomiting. According to the 
CSTE, confirmed cases required positive laboratory diagnostics, either isolation of the 
Bordatella pertussis bacterial organism or polymerase chain reaction detection of its 
genetic code, or epidemiological linkage (contact) to a lab-confirmed case. Probable 
cases fit the clinical criteria, but were either not laboratory confirmed or 
epidemiologically linked to another case. The 1997/2010 CSTE case definition was used 
for case classification. 
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In addition to the primary exposure and outcome, several covariates, both at the 
individual and group levels, were modeled to control for potential confounding (Figure 
4). Putative confounders that were associated with both the density of day cares and 
pertussis incidence were modeled at two levels. At the individual level, these included 
maternal age, maternal marital status (married, not married), race (white, black, other), 
ethnicity (Hispanic, non-Hispanic), maternal nativity (U.S. born, foreign born), child age 
(<1yr, >=1yr), child sex, maternal education (no high school diploma, high school 
diploma or GED, college and higher), maternal insurance status as time of birth (private 
insurance, no private insurance), and maternal parity (primiparous, multiparous). 
Individual level data were imported from several data sources including KIDS Plus IIS 
and Pennsylvania Department of Health Vital Statistics records. At the group level, 
variables included aggregate (i.e., averaged over the census tracts that comprised a 
neighborhood) measures of median age, percent white, black or other race, percent 
Hispanic, percent foreign born, percent single parent households, percent children less 
than age five, SES (percent with high school diploma, percent with bachelors degree, 
percent unemployed, median income), and population density. Group level data were 
imported from the American Community Survey, 2004-2009 5-year estimates, retrieved 
from American FactFinder. 
Vaccination uptake was operationalized on the individual level by assessing up-
to-date status, and on the community level by percent of up-to-date children (through age 
six) in each neighborhood. Up-to-date was defined as receipt of all pertussis antigen-
containing vaccinations (i.e., Diphtheria, Tetanus, acellular Pertussis [DTaP]) through the 
child’s age at pertussis diagnosis for cases (or matched age for controls). Doses 
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administered within two weeks of each other were considered duplicates and the later 
dose discarded. Vaccination data were derived from KIDS Plus IIS for cases and 
controls. 
 
2.3.3. Statistical Analysis 
We fit a mixed effects logistic regression model to these data to examine the 
association between day care density and individual pertussis incidence, accounting for 
contextual group differences by neighborhood. The model included two levels, individual 
(1st level) and group (2nd level, defined as neighborhood), and was iteratively built in four 
stages (Table 4). To evaluate the correlation among neighborhoods, an empty model was 
initially fit that described the variance in terms of the median odds ratio (MOR). The 
MOR defines the median probability of pertussis, moving from one neighborhood to 
another with greater reported pertussis; that is, the existence of neighborhood effects in 
reported pertussis incidence.101  
The second model introduced the primary exposure of day care density as a 
random slope to describe the area level variance explained by this predictor. Fitting day 
care density as a random effect allowed for the day care effect to vary among 
neighborhoods. The third model examined only the individual level variables in relation 
to a contextual pertussis difference, while the fourth model included both individual and 
community level variables. Estimation of parameters was performed using maximum 
likelihood methods, as is generally considered a robust multilevel procedure that guards 
against assumption violations (e.g., non-normal errors) when the sample size is 
sufficiently large and allows for estimation of neighborhood variance.97 Covariates were 
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included as potential confounders if they were associated with both the exposure and 
outcome (p < 0.20), or if they changed this relationship by >10%.98 Since child age was 
frequency matched between the cases and controls, it was automatically included in the 
model. Continuous variables were grand-mean centered to facilitate interpretation,99 and 
both median income and population density were log transformed for scaling in relation 
to the other covariates. 
At each stage in the model building process, the variance explained by the 
additional predictors was calculated in terms of the proportional change in area-level 
variance (PCV), and models were compared for goodness of fit using Akaike’s 
Information Criterion. The PCV is a straightforward assessment of the amount of 
variance changed between groups and individuals as additional parameters are introduced 
in the model, and yields a percent of variance explained by that parameter.102 This 
technique is particularly useful in multilevel model building as one of the goals is to 
identify sources of variability.  
The following equations represented the four models in Table 4, and further 
defined the underlying assumptions, for subject i in neighborhood j: 
1. Empty: Logit(πij) = αj 
…where logit(πij) is the pertussis case status with a Bernoulli distribution; and αj 
is the random intercept of neighborhoods with a normal distribution (0, σ2). 
2. Day Care (crude): Logit(πij) = αj + β1DayCarej + ϒ jDayCarej 
…where logit(πij) is the pertussis case status with a Bernoulli distribution; αj is the 
random intercept of neighborhoods with a normal distribution (0, σ2); β1 is the 
fixed effect for day care density; and ϒ j is the random slope of day care density. 
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3. Individual: Logit(πij) = αj + βmXij + βpUTDij 
…where logit(πij) is the pertussis case status with a Bernoulli distribution; αj is the 
random intercept of neighborhoods with a normal distribution (0, σ2); βm are the 
fixed effects for the individual covariates; and βp is the fixed effect for being up-
to-date on pertussis-antigen containing vaccines. 
4. Neighborhood: Logit(πij) = αj + β1DayCarej + ϒ jDayCarej + βmXij + βnXij + 
βpUTDij + βqNeighborhoodUTDij 
…where logit(πij) is the pertussis case status with a Bernoulli distribution; αj is the 
random intercept of neighborhoods with a normal distribution (0, σ2); β1 is the 
fixed effect for day care density; ϒ j is the random slope of day care density; βm 
are the fixed effects for the individual covariates; βn are the fixed effects for the 
community covariates; βp is the fixed effect for being up-to-date on pertussis-
antigen containing vaccines; and βq is the fixed effect for the percent of 
neighborhood children (through age six) being up-to-date on pertussis-antigen 
containing vaccines (herd effect). 
 
Neighborhoods for this study were well-defined aggregates of census tracts 
denoted by the City of Philadelphia.100 See Appendix E: Philadelphia Neighborhoods by 
Census Tract for mappings. Initially, neighborhoods were assumed to be independent 
from one another, an independent random effects structure. This assumption was then 
tested using Moran’s I measure of spatial autocorrelation on the area-level residuals (i.e., 
random intercepts of the neighborhoods) of the empty models and if significant 
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autocorrelation was detected (p<0.05), use of a conditional autoregressive random effect 
structure would be warranted.  
Using MLPowSim (University of Bristol, Bristol, UK) we estimated power for 
different sample sizes, magnitudes of association, and variations in the data. We assumed 
a fixed alpha of 5%, a desired beta of 20% (80% power), varying probabilities of living in 
high day care density areas, 2500 individuals (500 cases and 2000 controls), and ran 100 
simulations of the estimating model comparing Philadelphia neighborhoods as the 
clustering unit (n=45) to Philadelphia census tracts as the clustering unit (n=345). The 
estimating model represented the relationship between residing in a high day care density 
area (the independent variable) and reported incident pertussis (the dependent variable). 
An additional assumption is required for mixed effects models with random intercepts: 
the variance of the intercepts. A variance of 10 was used for the neighborhood clustering 
unit, and a variance of 5 was used for the census tract clustering unit, as the variance 
tends to decrease with increasing sizes. Results are shown in Table 5.  
Analyses were conducted using SAS 9.2 (SAS Institute Inc., Cary, NC) and R 
3.1.0 (R Foundation for Statistical Computing, Vienna, Austria). 
 
2.4. Results 
 The study sample included 2,050 children aged birth through six years, residing in 
45 Philadelphia neighborhoods for the years 2001 through 2013. Among these children, 
there were 410 cases of confirmed and probable pertussis reported to the Health 
Department. 
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2.4.1. Individual-level Characteristics 
 Table 6 reports individual-level characteristics of the study sample. Among 
pertussis cases, 64% of children were UTD on their DTaP vaccinations, compared with 
81% of controls (p<0.01). Cases were more likely to be of white race (p=0.03) and 
Hispanic ethnicity (p<0.01), and have mothers’ that were U.S. born (p<0.01) and 
multiparous (p=0.01). All other individual-level characteristics were not statistically 
significantly different between cases and controls, although maternal education and 
insurance at birth were marginally significant, with overall lower education (no high 
school diploma: 29% vs. 24%, p=0.06) and non-private insurance (68% vs. 63% p=0.05) 
among the cases. 
 
2.4.2. Neighborhood-level Characteristics 
 Table 7 reports neighborhood-level characteristics of the study sample. When 
comparing the cases and controls across the ecological characteristics of the 45 
Philadelphia neighborhoods, the only statistically significant difference was in the 
proportion of cases living in a neighborhood with an overall lower percentage of high 
school graduates (8.7% among cases vs 9.0% among controls, p=0.02). The density of 
day cares did not differ between cases and controls. While there was not statistical 
evidence of herd immunity associated with DTaP vaccination among children three 
months through six years, there was a borderline effect of more cases occurring in 
neighborhoods with lower DTaP vaccinations rates (p=0.05). 
Table 8 and Figure 5 show the distribution of cases in each neighborhood. The 
greatest number of cases (n=24) was reported from the South Broad-Girard Estates 
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neighborhood in South Philadelphia, while the fewest cases (n=3) were reported from the 
Center City, Fairmount-Spring Garden, and Sharswood-Stanton neighborhoods in Central 
Philadelphia and the Overbrook Park-Wynnefield Heights neighborhood in West 
Philadelphia. The median number of cases per neighborhood was six (interquartile range: 
seven). 
 
2.4.3. Association of Day Cares and Pertussis  
The day care density measure was chosen for statistical modeling as it was the 
most parsimonious predictor in the models with the lowest AIC/BIC among all of the day 
care variables. Adjusting the number of day cares by neighborhood area, as opposed to 
the raw count or per capita, allows for neighborhoods with more day cares per square 
mile to have a higher level of exposure, as the proximity of day cares to the residents is 
the risk factor of interest. More day cares per neighborhood may mean both an increased 
likelihood of use by the local residents and more sources for pathogen transmission.  
 Table 9 presents the results of the multilevel analysis, comparing cases and 
controls among individual- and neighborhood-level covariates. Moran’s test for spatial 
autocorrelation was not statistically significant (p=0.20), therefore we used an 
independent random effects structure. In both the crude (OR=1.0, 95% CI: 0.8, 1.4) and 
fully adjusted (OR=1.0, 95% CI: 0.6, 1.7) multilevel models, there was no evidence of a 
relationship between the density of day cares in a given neighborhood (Figure 6) and 
reported incident pertussis (Figure 5). 
 We observed evidence of reported pertussis incidence corresponding to the 
neighborhood where one resides: for a given child, the median odds of pertussis were 1.3 
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times higher (95% CrI: 1.1, 1.6) solely based on which neighborhood he or she lives. The 
inclusion of individual-level and neighborhood-level potential confounders did little to 
explain the variability in reported pertussis cases (proportionate change in variance: 
+62.6% for individual-level covariates and +23.5% for individual-level and 
neighborhood-level covariates, relative to the empty model), as well as mitigated the 
neighborhood pertussis effect (MOR 1.4, 95% CrI: 0.8, 2.0).  
 
2.5. Discussion 
In this multilevel analysis, we examined the distribution of reported pertussis 
cases throughout Philadelphia between 2001 and 2013. Our main finding was a possible 
clustering effect corresponding to an increase risk of disease based solely on the 
neighborhood where one resides. Secondary findings suggest that correlates of pertussis 
infection in this study sample are driven by familial and individual factors rather than 
ecological exposures. 
Determinants of infectious disease not only include biologic susceptibility (such 
as immune status) but also the community one lives in.8 For respiratory diseases, like 
pertussis, cases often occur in clustered outbreaks, and may be related to an increase in 
vaccine exemptions.18 Pertussis has a basic reproductive rate estimated between 15 and 
17 secondary cases for each primary case, is a highly contagious disease, and therefore 
requires a high number of immune individuals living in an area (92-95%) to reach the 
herd threshold.9 Although we observed differential disease distribution based solely on 
the neighborhood, lower vaccination rates in those neighborhoods cannot be inferred as 
we only had vaccination data on children three months to six years. 
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The use of a multilevel analytic approach allowed us to account for the correlation 
among independent observations (i.e., the clustering effect) that otherwise may have been 
violated in a standard regression model. If we ignored the clustering phenomenon, the 
standard errors in the regression modeling would have been underestimated yielding a 
biased result.101,102Analyzing the data at multiple levels allowed the nesting of individuals 
into clustering units where the correlation within a clustered unit will be smaller than the 
correlation across clustered units. As observed, this translated into a reported incidence of 
pertussis that was dependent upon the neighborhood, although spatial autocorrelation was 
not detected.  
While we hypothesized the source of pertussis may have been related to the 
density of day cares in the neighborhoods (hence more opportunity for pathogen 
transmission) we did not observe evidence of this possibly attributed to misclassification 
of the day care density variable. For example, it may be possible that a day care effect 
was present in the lower SES neighborhoods, where day cares are less likely to be 
captured in our data, and disease rates are greater. Further, it was not possible in the study 
sample to determine where children ultimately attended day care; it may not have been 
within the local neighborhood as the increase in childcare services offered at work103 is 
replacing day care use near the home. There may have also been an inverse, protective 
relationship with day care density due to the vaccination requirement within 90 days of 
child enrollment,104 potentially conferring greater protection among these children. Yet 
this requirement is still subject to non-medical exemptions from vaccination,96 as well as 
only enforceable among day cares registered with the state. In short, any day care effect 
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would be difficult to tease out without full knowledge of all day cares in the city and 
home neighborhoods for all attendees.  
There are several potential limitations to this research. First, pertussis is likely 
underreported, as it requires both a provider encounter and the correct test to be ordered 
to trigger the passive surveillance system. If the unreported cases were more likely to be 
from clusters with higher density of day cares, the magnitude of association may also be 
underestimated in this analysis. Second, due to the time periods examined in this study, 
there may be population migrations. For example, if families were likely to in-migrate 
because of availability of day care, and these children were at higher risk for pertussis, 
the odds ratio could also be underestimated. Third, as vaccination data is derived from the 
citywide IIS, the records are subject to the same limitations that any IIS is subject to, 
namely the records are incorrect or incomplete.105 Based on the experience of the PDPH, 
KIDS Plus IIS captures the majority of vaccinations and is regularly validated by nursing 
staff who visit clinics to ensure vaccination records are complete. Fourth, despite not 
detecting spatial autocorrelation using Moran’s measure, a mixed effects regression 
model with a conditional autoregressive structure (as opposed to the independent 
structure assumed) may still be useful to examine ecological determinants and would be 
appropriate for future work. Last, the primary exposure of day cares may be subject to 
misclassification by several mechanisms including 1) the Pennsylvania DPW not 
capturing unregistered day cares, 2) day cares changing over time, and 3) the day care in 
the clustering unit not serving the community in that area. For example, we may 
underestimate the magnitude of effect if there were more pertussis cases in 
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neighborhoods with more unregistered day cares, perhaps due to less stringent (or 
nonexistent) vaccination requirements. 
In this analysis, we detected a neighborhood effect of pertussis incidence. Solely 
based on the neighborhood where a given child lives may increase their risk of reported 
pertussis. From a Health Department perspective, the highest risk neighborhoods should 
be targeted for vaccine campaigns and further research to identify the etiologic risk 
factors. 
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2.6. Tables and Figures 
Table 3. Day care classification by number of children. 
Day Care Category Size DPW Licensed? DPW Registered? Potential for Bias 
Child Care Center ≥7 children Yes Yes Minimal 
Group Child Care Homes 7 – 12 children Yes Yes Minimal 
Family Child Care Homes 4 – 6 children No Yes Moderate 
Unregistered Day Care* Unknown No No High 
*This category of day cares are not captured by the State and therefore represent the greatest potential for 
bias if more pertussis cases occur in areas with more unregistered day cares. 
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Table 4. Multilevel modeling approach. 
Model Type Outcome 
(Level) 
Covariates (Level) Meaning 
Empty Random 
intercept 
Pertussis 
(individual) 
None Correlation among the groups 
and prevalence of pertussis 
Day Care 
(crude) 
Random 
slope + 
intercept 
Pertussis 
(individual) 
Density of day cares 
(community) 
Unadjusted pertussis OR of the 
day care effect with cluster and 
day care variance 
Individual Random 
intercept 
Pertussis 
(individual) 
All individual-level 
covariates  
Adjusted pertussis OR for 
individual level variables with 
cluster variance 
Neighborhood Random 
slope + 
intercept 
Pertussis 
(individual) 
All individual- and 
community-level 
covariates  
Adjusted pertussis OR for 
individual and community level 
variables with cluster and day 
care variance 
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Table 5. Power and sample size estimates. 
Clustering 
unit 
Avg N 
indiv per 
cluster 
Variance 
of the 
intercepts 
Probability of 
living in high day 
care density 
OR for 
pertussis 
in high day 
care density 
Power (95% 
simulation 
interval) 
Neighborhood 56 10 75% 2.00 100% (100%, 
100%) 
Neighborhood 56 10 50% 2.00 100% (100%, 
100%) 
Neighborhood 56 10 25% 2.00 100% (100%, 
100%) 
Census Tract 7 5 75% 2.00 99.0% (97.0%, 
100%) 
Census Tract 7 5 50% 2.00 100% (100%, 
100%) 
Census Tract 7 5 25% 2.00 100% (100%, 
100%) 
Neighborhood 56 10 75% 1.50 83.0% (75.6%, 
90.4%) 
Neighborhood 56 10 50% 1.50 94.0% (89.3%, 
98.7%) 
Neighborhood 56 10 25% 1.50 86.0% (79.2%, 
92.8%) 
Census Tract 7 5 75% 1.50 83.0% (75.6%, 
90.4%) 
Census Tract 7 5 50% 1.50 86.0% (79.2%, 
92.8%) 
Census Tract 7 5 25% 1.50 77.0% (68.8%, 
85.2%) 
Neighborhood 56 10 75% 1.25 40.0% (30.4%, 
49.6%) 
Neighborhood 56 10 50% 1.25 48.0% (38.2%, 
57.8%) 
Neighborhood 56 10 25% 1.25 36.0% (26.6%, 
45.4%) 
Census Tract 7 5 75% 1.25 36.0% (26.6%, 
45.4%) 
Census Tract 7 5 50% 1.25 46.0% (36.2%, 
55.8%) 
Census Tract 7 5 25% 1.25 34.0% (24.7%, 
43.3%) 
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Table 6. Individual-level characteristics of study sample and comparison of cases 
and controls. 
 Characteristic Cases (n=410) Controls (n=1640) All (n=2050) P-valuea 
Child     
 Age, yrsb    0.94 
  <1 290 (70.7) 1163 (70.9) 1453 (70.9)  
  >=1 120 (29.3) 477 (29.1) 597 (29.1)  
 Gender    0.17 
  Female 220 (53.7) 818 (49.9) 1038 (50.6)  
  Male 190 (46.3) 822 (50.1) 1012 (49.4)  
 Race (n=1896)    0.03 
  White 122 (36.6) 460 (29.4) 582 (30.7)  
  Black 163 (48.9) 860 (55.0) 1023 (54.0)  
  Other 48 (14.4) 243 (15.5) 291 (15.3)  
 Ethnicity (n=1904)    <0.01 
  Non-Hispanic 258 (75.7) 1311 (83.9) 1569 (82.4)  
  Hispanic 83 (24.3) 252 (16.1) 335 (17.6)  
 DTaP status (n=1161)    <0.01 
  Not UTD 84 (35.9) 181 (19.5) 265 (22.8)  
  UTD 150 (64.1) 746 (80.5) 896 (77.2)  
Maternal     
 Age, yrs (n=1975) 27.0 (7.0) 27.5 (6.6) 27.4 (6.7) 0.15 
 Marital status (n=1974)    0.40 
  Not married 241 (66.4) 1032 (64.1) 1273 (64.5)  
  Married 122 (33.6) 579 (35.9) 701 (35.5)  
 Nativity (n=1825)    <0.01 
  U.S. born 294 (88.0) 1204 (80.8) 1498 (82.1)  
  Foreign born 40 (12.0) 287 (19.2) 327 (17.9)  
 Education (n=1937)    0.06 
  No high school diploma 101 (28.7) 386 (24.4) 487 (25.1)  
  High school diploma/GED 122 (34.7) 513 (32.4) 635 (32.8)  
  College or higher 129 (36.6) 686 (43.3) 815 (42.1)  
 Insurance at birth (n=2045)    0.05 
  No private insurance 278 (67.8) 1025 (62.7) 1303 (63.7)  
  Private insurance 132 (32.2) 610 (37.3) 742 (36.3)  
 Parity (n=1943)    0.01 
  Primiparous 121 (34.4) 667 (41.9) 788 (40.6)  
  Multiparous 231 (65.6) 924 (58.1) 1155 (59.4)  
Mean (standard deviation) for continuous measures; N (percent) for categorical measures; DTaP, 
Diphtheria, Tetanus, acellular Pertussis; UTD, up-to-date. 
a Significance testing comparing cases and controls using Student’s t-test for normally distributed data, 
Wilcoxon Rank Sum for non-normally distributed data, and Chi-squared testing for categorical data. 
b Frequency matched between cases and controls. 
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Table 7. Neighborhood-level characteristics of study sample and comparison of 
cases and controls. 
Characteristic Cases (n=410) Controls (n=1632) All (n=2042) P-valuea 
Median age, yrs 34.4 (4.7) 34.7 (4.6) 34.6 (4.6) 0.45 
White race, % 41.5 (29.9) 41.2 (30.4) 41.3 (30.3) 0.96 
Black race, % 46.1 (33.2) 47.2 (33.6) 47.0 (33.5) 0.68 
Other race, % 14.3 (12.2) 13.6 (12.2) 13.7 (12.2) 0.30 
Hispanic ethnicity, % 13.0 (16.4) 12.2 (15.7) 12.4 (15.9) 0.35 
Foreign born, % 10.1 (6.8) 10.0 (7.0) 10.0 (7.0) 0.87 
Single parent household, % 29.9 (11.2) 29.1 (11.7) 29.3 (11.6) 0.27 
Children under 5 yrs, % 7.5 (2.0) 7.2 (2.1) 7.3 (2.1) 0.06 
High school graduate, % 75.6 (8.7) 76.9 (9.0) 76.7 (8.9) 0.02 
College graduate, % 18.1 (12.5) 19.5 (14.6) 19.2 (14.2) 0.11 
Unemployed, % 42.0 (6.4) 41.5 (6.8) 41.6 (6.7) 0.23 
Median income, USD 35004 (11654) 36075 (12331) 35860 (12203) 0.24b 
Population density, n/sq. mi. 19578 (7356) 18877 (6598) 19018 (6761) 0.36b 
Children 3mos – 6yrs DTaP UTD, % 72.0 (5.9) 71.1 (6.9) 71.3 (6.8) 0.05 
Density of day caresc 24.4 (16.4) 24.6 (16.0) 24.5 (16.3) 0.64b 
Mean (standard deviation) for continuous measures; N (percent) for categorical measures; DTaP, 
Diphtheria, Tetanus, acellular Pertussis; UTD, up-to-date. 
a Significance testing comparing cases and controls using a mixed effect multilevel logistic regression 
model with each characteristic separately fit as a fixed effect (grand-mean centered), and neighborhood as 
a random intercept. 
b Log transformed for significance testing. 
c Density = number of day cares / area of neighborhood in sq. mi. 
  
	  	  
 
53	  
Table 8. Distribution of cases of childhood pertussis by 45 Philadelphia 
neighborhoods, 2001-2013. 
 Neighborhood No. of Cases 
1.  South Broad-Girard Estates  24 
2.  Paschall-Kingsessing  21 
3.  Juniata Park-Harrowgate  19 
4.  Mill Creek-Parkside  17 
5.  Snyder-Whitman  17 
6.  Hunting Park-Fairhill  16 
7.  Northern Liberties-West Kensington  16 
8.  Olney-Feltonville  15 
9.  Haddington-Overbrook  14 
10.  Nicetown-Tioga  14 
11.  Southwark-Bella Vista  14 
12.  Lawndale-Crescentville  12 
13.  Torresdale-North  12 
14.  Strawberry Mansion  11 
15.  Wissinoming-Tacony  11 
16.  Mayfair-Holmesburg  10 
17.  Schuylkill-Point Breeze  10 
18.  Upper Kensington  10 
19.  Cobbs Creek  9 
20.  Frankford  9 
21.  University City  8 
22.  Somerton  7 
23.  Chestnut Hill-W. Mt. Airy  6 
24.  Eastwick-Elmwood  6 
25.  Grays Ferry-Passyunk  6 
26.  Lower Kensington  6 
27.  Ogontz  6 
28.  Rhawnhurst-Fox Chase  6 
29.  Richmond-Bridesburg  6 
30.  Roxborough-Manayunk  6 
31.  Torresdale-S.-Pennypack Park  6 
32.  West Oak Lane-Cedarbrook  6 
33.  East Falls-Westside  5 
34.  Germantown  5 
35.  Logan  5 
36.  Oak Lane-Fernrock  5 
37.  Oxford Circle  5 
38.  Poplar-Temple  5 
39.  Bustleton  4 
40.  East Mt. Airy  4 
41.  Pennsport- Queen Village  4 
42.  Center City  3 
43.  Fairmount-Spring Garden  3 
44.  Overbrook Park-Wynnefield Heights  3 
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45.  Sharswood-Stanton  3 
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Table 9. Measures of association between individual and neighborhood 
characteristics and pertussis infection, and measures of variation or clustering in 45 
neighborhoods in Philadelphia, PA. 
  Multilevel model 
 Characteristic Empty 
modela 
(n=2042) 
Day care 
(crude) 
modela 
(n=2042) 
Model w/ 
individual 
level varsa 
(n=943) 
Model w/ 
neighborhood 
level varsa 
(n=943) 
Measures of fixed effect associations (OR of pertussis, 95% CI) 
Individual level     
 Child age, yrs     
  <1   Ref Ref 
  >=1   1.1 (0.8, 1.6) 1.1 (0.8, 1.5) 
 Child race     
  White   Ref Ref 
  Black   0.5 (0.3, 0.8) 0.5 (0.3, 0.7) 
  Other   0.7 (0.3, 1.3) 0.6 (0.3, 1.2) 
 Child ethnicity     
  Non-Hispanic   Ref Ref 
  Hispanic   1.8 (1.1, 2.9) 1.8 (1.1, 2.9) 
 Child DTaP status     
  Not UTD   Ref Ref 
  UTD   0.4 (0.3, 0.6) 0.4 (0.3, 0.6) 
 Maternal nativity     
  U.S. born   Ref Ref 
  Foreign born   0.2 (0.1, 0.5) 0.3 (0.1, 0.5) 
 Maternal education     
  No high school diploma   Ref Ref 
  High school diploma/GED   0.9 (0.6, 1.5) 1.0 (0.6, 1.6) 
  College or higher   0.9 (0.5, 1.4) 1.0 (0.6, 1.6) 
 Maternal parity     
  Primiparous   Ref Ref 
  Multiparous   1.4 (1.0, 2.1) 1.4 (1.0, 2.1) 
Neighborhood level     
 Density of day caresb  1.0 (1.0, 1.0)  1.0 (1.0, 1.0) 
 High school graduate, %    1.0 (1.0, 1.0) 
 Children 3mos – 6yrs DTaP UTD, %    1.0 (1.0, 1.1) 
Measures of variation or clustering 
Area level variance 0.289 0.281 0.470 0.357 
PCV  -2.8% +67.3% -24.0% 
MOR (95% CrI) 1.3 (1.1, 1.6) 1.3 (1.1, 1.6) 1.6 (1.2, 2.1) 1.4 (0.8, 2.0) 
DTaP, Diphtheria, Tetanus, acellular Pertussis; UTD, up-to-date; SE, standard error; PCV, proportional 
change in variance; OR, odds ratio; MOR, median odds ratio; CI, confidence interval; CrI, credible 
interval. 
a Mixed effect multilevel logistic regression model with each characteristic fit as a fixed effect (grand-mean 
centered for continuous data), day care density as a random slope, and neighborhood as a random 
intercept. 
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b Density = number of day cares / area of neighborhood in sq. mi.  
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Figure 4. Conceptual diagram of etiologic pathway. 
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Figure 5. Cases of childhood pertussis by 45 Philadelphia neighborhoods, 2001-2013. 
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Figure 6. Day care density by 45 Philadelphia neighborhoods. 
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3. CHOICE of MEASURES of VACCINATION and ESTIMATES of RISK of 
PEDIATRIC PERTUSSIS 
 
 
3.1. Abstract 
Background: Vaccination uptake at the individual level can be assessed in a variety of 
ways, including traditional measures of being up-to-date (UTD), measures of UTD that 
consider dose timing, like age-appropriate vaccination, and risk reduction from individual 
doses. This analysis compared methods of operationalizing vaccination uptake and 
corresponding risk of pertussis. 
Methods: City-wide case-control study of children in Philadelphia aged three months 
through six years, between 2001 and 2013. Multiple logistic regression was used to 
isolate the independent effects of each measure of vaccination uptake and the 
corresponding relative odds of pertussis. 
Results: Being UTD on vaccinations was associated with a 50% reduction in risk of 
pertussis (OR 0.5, 95% CI: 0.3, 0.7). Evaluation of delayed receipt of vaccine versus on-
time UTD yielded similar results. There was a 30% decrease in risk of pertussis for each 
additional dose received; the greatest reduction in pertussis infection was observed from 
the first (OR 0.4, 95% CI: 0.2, 0.9) and second dose (OR 0.2, 95% CI: 0.1, 0.3). 
Additional doses conferred minimal additional protection in this age group. 
Conclusion: Examining vaccination status by individual doses may offer improved 
predictive capacity for identifying children at risk for pertussis infection compared to the 
traditional UTD measure. 
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3.2. Introduction 
Vaccination coverage is a common measure of individuals vaccinated in a 
community and can represent vaccine program effectiveness. It is assessed by examining 
individual immunization records and summarizing to the population, such as reporting 
percent vaccinated. In assessing the individual immunization records, the researcher 
needs to choose the proper metric. One frequently used measure is being up-to-date 
(UTD) on vaccinations, which implies all recommended doses of a vaccine have been 
administered by a specific age.63,65,66,76 Depending on the study, UTD may include the 
nuanced timing of a dose, or whether the dose fell within the vaccine schedule 
recommendations, and therefore studies employing this measure may be examining 
different phenomenon from studies that examine UTD without considering dose 
timing.72,79,81,106 When the timing of a dose is considered, the metric is often referred to as 
delayed or age-appropriate vaccination.   
Despite overall high vaccination coverage levels (US national coverage estimates 
of four DTaP doses by 24 months of age are close to 80%),107 this may not reflect the 
delays in receiving vaccination. A study by Luman et al. found that 23% of children who 
may have traditionally been classified as UTD at 24 months were in fact undervaccinated 
during a portion of this time, and 42% had delays in more than one vaccine.108 This 
leaves the child potentially vulnerable during the undervaccinated period. Compared to 
age-appropriate vaccination status, Glanz et al. reported children were up to 28.4 times as 
likely to be diagnosed with pertussis (95% confidence interval, 3.2-252.6) when they 
were undervaccinated by four doses, and 18.6 times as likely (95% confidence interval, 
	  	  
 
62	  
4.9-70.0) when they were undervaccinated by three doses.109 Although as another study 
has noted, even undervaccinated children received a base level of protection against 
severe diseases compared to non-vaccinated individuals.110 
Given multiple methods of assessing vaccination status and protection against 
disease, comparison across studies may be hindered by the specific type of vaccination 
coverage definition. Using national immunization data, Dombkowski et al. revealed 
important characteristics like education and insurance status might be ignored when 
examining vaccination coverage as a dichotomous UTD variable versus a multi-
categorical age-appropriate vaccination variable.12 In addition to identifying differences 
in vaccination characteristics, it is also important to identify if there are differences in 
disease risk, the focus of the present study.  
Therefore, it is necessary to compare the measures directly in the same 
population. We focused on reported incident cases of pertussis in the Philadelphia 
population of children between 2001 and 2013, and sought to compare the different 
vaccination coverage metrics as predictors of disease. This disease is of particular interest 
as there has been a sharp increase in cases over recent years, both locally and nationally, 
and in fact, in 2012 Philadelphia experienced twice as many cases as in the previous 
year.34 For the primary exposure, we examined differing metrics of vaccination coverage 
and their corresponding impact on the risk of pediatric pertussis.  
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3.3. Methods 
3.3.1. Source Population and Study Sample 
The source population for this study was children who were registered in KIDS 
Plus, the city’s immunization information system (IIS). The KIDS Plus IIS represents an 
open cohort of children who were born in Philadelphia or received vaccinations from 
Philadelphia-based providers and it was used to derive the study sample of both incident 
pertussis cases and controls for a nested case-control analysis. Potential pertussis cases 
were reported to the Philadelphia Department of Public Health (PDPH) as mandated by 
the Philadelphia Health Code.22 Controls were selected using incidence density sampling 
from non-case children in KIDS Plus IIS at a 4:1 control to case ratio and frequency 
matched by date of birth to within two weeks. The study sample was restricted to children 
born between 1-Jan-2001 and 31-Dec-2013, and only included children aged three 
months through six years to capture the full five-dose series of pertussis vaccine in 
childhood. Given the very high pediatric vaccination rates in Philadelphia, children with 
fewer than two vaccines (any type) were excluded as these children were considered born 
in Philadelphia but moved or resided elsewhere. This study was approved by the 
Institutional Review Boards for the City of Philadelphia and Drexel University 
(Philadelphia, PA). 
 
3.3.2. Exposure, Outcome, and Covariates 
Vaccination data were derived from KIDS Plus IIS for cases and controls. All 
pertussis antigen-containing vaccinations (i.e., Diphtheria, Tetanus, acellular Pertussis) 
through the child’s present age were included. Doses administered within two weeks of 
	  	  
 
64	  
each other were considered duplicates and the later dose discarded. Using the 2013 
CDC/ACIP schedule (see Appendix A: Vaccination Schedules), there were five 
recommended doses of DTaP by age six. 
The primary exposure for this study was vaccination status operationalized in four 
ways: UTD (the commonly used metric), delayed UTD, and cumulative number of doses 
handled both continuously and categorically (Figure 7). Children were considered UTD if 
they received all vaccinations recommended for their age group by their current age; 
otherwise they were not UTD. The second measure, delayed UTD, was assessed by 
establishing a valid timeframe for each individual dose (Table 10), and then comparing 
timing of dose delivery. If all doses where administered, but one or more were not 
delivered within the valid timeframe, the child was deemed “delayed UTD”. If all doses 
were administered within the timeframe, they were deemed “on time UTD.” One or more 
doses missing would classify the child as not UTD. Several algorithms have been 
developed to classify delayed vaccination based on the Advisory Committee on 
Immunization Practices guidelines;13 ours (Table 10) is adapted from expert clinical 
opinion and these references.109,110 Lastly, the cumulative number of DTaP doses was 
handled in two ways: 1) summed through their current age and categorized, and 2) 
summed through their current age and treated as a continuous variable for trend 
estimation. It should be noted that the evaluation of continuous doses on risk does not 
establish a dose-response relationship. With each additional dose we cannot assume a 
corresponding decrease in disease risk, as potentially a single DTaP vaccination could 
explain the entire risk reduction.111 
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The outcome under study was reported incident cases of confirmed or probable 
pertussis, defined by the Council of State and Territorial Epidemiologists (CSTE) as a 
cough illness, without other apparent causes, lasting at least two weeks, with one or more 
paroxysms of coughing, inspiratory "whoop," or posttussive vomiting. According to the 
CSTE, confirmed cases required positive laboratory diagnostics, either isolation of the 
Bordatella pertussis bacterial organism or polymerase chain reaction detection of its 
genetic code, or epidemiological linkage (contact) to a lab-confirmed case. Probable 
cases fit the clinical criteria, but were either not laboratory confirmed or 
epidemiologically linked to another case. The CSTE definition at the time of the reported 
case was used for case classification. Given the last two substantive changes to the 
pertussis case definitions were in 1997 (positive PCR with clinical components) and 2014 
(addition of infant apnea to the clinical criteria), our study period of 2001 through 2013 
should all be classified per the 1997 definition. 
In addition to the primary exposure and outcome, several covariates were 
examined for potential confounding (Figure 8) including maternal age, maternal marital 
status (married, not married), race (white, black, other), ethnicity (Hispanic, non-
Hispanic), maternal nativity (U.S. born, foreign born), child age (<1yr, >=1yr), child sex, 
maternal education (no high school diploma, high school diploma or GED, college and 
higher), maternal insurance status as time of birth (private insurance, no private 
insurance), and maternal parity (primiparous, multiparous). A priori, we considered effect 
modification by age, race, and maternal parity, with vaccination status. Data 
completeness was examined by comparing the study sample via a missing data indicator 
to see if any covariates were more likely to contain missing data when performing a 
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complete case analysis. All data were imported from KIDS Plus IIS and Pennsylvania 
Department of Health Vital Statistics records. 
 
3.3.3. Statistical Analysis 
Descriptive statistics were used to assess crude relationships between the 
covariates and the primary exposure and outcome. For continuous variables, Student’s t-
test for normally distributed data and Wilcoxon Rank Sum test for non-normally 
distributed data were used to test for differences between groups. For categorical data 
Chi-squared testing was used to examine relationship between groups. Results were said 
to be statistically significant if corresponding p-values were <0.05.  
To control for potential confounding, modeling interaction, and determine the 
most predictive vaccination uptake measure we used multivariable unconditional logistic 
regression. Estimation of parameters was performed using maximum likelihood methods. 
The model was fit in two phases (Table 11). Initially, a crude model considered only the 
bivariate relationship between vaccination uptake and case status, and the odds ratio 
represented the crude association. The model was then enhanced by adding the covariates 
enumerated in Figure 8. Covariates were included as potential confounders if they were 
associated with both the exposure and outcome (p<0.20), or if they changed this 
relationship by >10%.98 Since child age was frequency matched between the cases and 
controls, it was automatically included in the model. This final model represented the 
adjusted odds of exposure (and disease) between vaccination uptake and pertussis. 
Vaccine effectiveness (VE) was defined as 1 – OR. 
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Interaction was assessed by stratifying the population to examine change in 
association estimates and statistically confirmed through comparing models with and 
without the interaction terms via a likelihood ratio test (p<0.05). Multicollinearity was 
assessed by ensuring the variance inflation factor for each parameter was < 10. Akaike 
information criterion (AIC) and Bayesian information criterion (BIC), measures of model 
fit, determined the most parsimonious vaccination uptake model, and allowed us to 
establish whether a particular measure performed better in explaining the variability of 
the data. Bootstrapping was employed to estimate the precision around the AIC and BIC 
statistics for each of final models. 
Using MLPowSim (University of Bristol, Bristol, UK) we estimated power for 
different sample sizes, magnitudes of association, and variations in the data. We assumed 
a fixed alpha of 5%, a desired beta of 20% (80% power), a prevalence of UTD of 85%*, 
and ran 1000 simulations of the estimating model at a step size of 500 individuals (range 
500 to 2500). The estimating model represented the relationship between being UTD (the 
independent variable) and reported incident pertussis (the dependent variable). Results 
are shown in Table 12.  
Analyses were conducted using SAS 9.2 (SAS Institute Inc., Cary, NC) and R 
3.1.0 (R Foundation for Statistical Computing, Vienna, Austria). Missing  
 
3.4. Results 
 From 2001 through 2013, there were 235 pertussis cases that met the inclusion 
criteria, and 940 controls, for a total sample size of 1175 children aged three months 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* 85% prevalence of UTD on 4-DTaPs based on the CDC National Immunization Survey 
(NIS) - Children (19-35 months) for Philadelphia County, various years.  
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through six years in Philadelphia, PA. Vaccination characteristics of cases and controls 
are provided in Table 13. In general, cases had fewer total vaccinations of any type (mean 
of 14.9 versus 16.0, p=0.03) as well as fewer total pertussis vaccinations (mean of 2.1 
versus 2.6, p<0.01). When broken down by individual doses, 21% of cases had no DTaP 
vaccinations, compared to only 6% of controls (p<0.01). A crude dose-response on 
reduction of disease incidence was not observed – additional doses were inconsistent in 
their effects, with only the effect of receipt of two doses being statistically significant 
(7% of cases versus 14% of controls, p=0.01). Cases were only UTD on their pertussis 
vaccinations 64% of the time compared to 80% of the time for controls (p<0.01). We did 
not observe any waning immunity effect, as both cases and controls had approximately 
equivalent time since last DTaP dose (mean of 45 and 43 weeks, respectively; p=0.65).  
Table 14 presents the sociodemographic characteristics of this population. Cases 
were more likely to be of white race (42% versus 29%, p<0.01), Hispanic ethnicity (21% 
versus 15%, p=0.04), and have U.S. born mothers (90% versus 81%, p<0.01). Pertussis 
cases tended to be female (57%) more than controls (50%), although the result was 
borderline (p=0.05). We compared the sociodemographic characteristics by UTD 
vaccination status to inform our confounder selection (Table 15). As 32 children (one 
case and 31 controls) could not be classified as UTD/not UTD using our algorithm (for 
example, due to age ineligibility), there were 1143 eligible cases and controls for the 
crude vaccination analyses. Children who were one year of age or older (53% versus 
45%, p=0.01), were privately insured for delivery (47% versus 36%, p=0.01), and first 
born (43% versus 29%, p<0.01) were more likely to be UTD on their pertussis 
vaccinations. Child age and race, and maternal parity were subsequently included in our 
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multivariable regression modeling to control for potential confounding. To ensure the 
missing data on these three variables, as well as vaccination history, did not threaten 
internal validity, we compared the study participant characteristics by a missing data 
indicator (Table 16). Interestingly, we noted Hispanic children were more likely to have 
missing data (p<0.01). A mechanism for this missing data could not be identified and we 
treated it as ignorable. 
To compare the prognostic capacity of each measure of vaccine uptake, we fit five 
logistic regression models predicting reported pertussis incidence (case or control) from 
vaccination uptake controlling for child age and race, and maternal parity (Table 17). The 
five models correspond to the vaccination uptake measures: UTD versus not UTD, 
delayed UTD versus not UTD, categorical number of pertussis vaccinations versus zero 
doses, and continuous number of pertussis vaccinations. For the fifth regression model, 
we combined two indicators of vaccine uptake: being UTD and the categorical number of 
pertussis vaccinations to evaluate the independent effects of being UTD while adjusting 
for the number of vaccine doses received. The UTD and number of doses exposure 
measures assessed related albeit separate concepts, where UTD incorporates age 
dependence and can have differing number of doses depending on the age of the child. 
Multicollinearity, estimated from the variance inflation factor, was not observed with the 
combination measure and the model converged successfully. 
Being UTD on pertussis vaccinations corresponded with a 50% vaccine 
effectiveness in reducing reported infection, controlling for sociodemographic 
differences, compared to being not UTD (OR 0.5, 95% CI: 0.3, 0.7). When UTD was 
decomposed into delayed UTD and on time UTD, delayed UTD resulted in a 70% 
	  	  
 
70	  
reduction in pertussis incidence (OR 0.3, 95% CI: 0.2, 0.6) compared to being not UTD, 
while on time UTD resulted in a 50% reduction (OR 0.5, 95% CI: 0.4, 0.8) compared to 
being not UTD (p=0.11, comparison of delayed UTD and on time UTD). In terms of 
individual doses, receiving one dose resulted in a 50% vaccine effectiveness (OR 0.5, 
95% CI: 0.3, 0.8), while receiving two or more doses resulted in better than 80% vaccine 
effectiveness, compared to no vaccinations. Taken as a continuous measure, each 
additional shot corresponded to a 30% reduction in risk of pertussis (OR 0.7, 95% CI: 
0.6, 0.8), and demonstrated a clear trend that additional doses lowered one’s risk, with the 
first (OR 0.5, 95% CI: 0.3, 0.8) and second dose (OR 0.2, 95% CI: 0.1, 0.3) conferring 
the greatest protection. Additional doses of vaccine (beyond two doses) did not confer 
increased effectiveness in preventing infection for the entire study group (all ages); 
however when we restricted the study sample to children ages two and younger, there 
was a clear immediate benefit to the first booster dose (4th dose overall), recommended 
between ages 15 – 18 months (OR 0.1, 95% CI: 0.0, 0.2; data not shown). As shown in 
Figure 9, gradually increasing the maximum age of the study sample attenuated the 
booster dose’s effectiveness. 
When combining UTD and the number of doses into a single regression model, 
decreased risk for infection was associated with the number of doses, and not UTD status, 
adjusted for child age and race, and maternal parity. Compared to the UTD model alone, 
this combination model better explained the risk-reduction in pertussis attributed to 
vaccination status (p<0.001, for likelihood ratio test). We did not observe improved 
model fit, as assessed by AIC and BIC, for any given vaccination metric (Figure 10). 
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After controlling for vaccination status and maternal parity, black and African 
American children were about 40% less likely to be identified with pertussis compared to 
white children (OR 0.6, p<0.01) across all vaccination models. Similar reduction in 
reported incidence was observed for other non-white races (OR 0.5 – 0.6, p<0.05). Being 
multiparous (having two or more live births) tended to increase the likelihood of reported 
pertussis about 40% on average (OR 1.4, p=0.05). For models that did not incorporate an 
age-dependent vaccination measure (i.e., categorical or continuous number of doses) age 
was an independent predictor of disease, where children one year of age and older had at 
least a two-fold increase in risk of pertussis (OR 2.2 – 2.5, p<0.05), controlling for 
vaccination and other sociodemographic variables. 
 We had an a priori interest in examining effect modification with vaccination 
status by child age, child race, and maternal parity. When stratified by these variables, the 
magnitude of effect between UTD vaccination status and reported pertussis incidence did 
not meaningfully differ between strata and there was no statistical evidence of an 
interaction (data not shown). 
 
3.5. Discussion 
In this population-based case-control study, we compared vaccination 
characteristics of children with and without pertussis. Our principal finding is that the risk 
reduction observed from examining vaccination history as the number of doses may be of 
greater value than examining history by UTD status alone, as the number of doses 
became the primary driver of the association between vaccination and pertussis in the 
model that considered both measures of vaccination status. These results suggest the 
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greatest reduction in risk of pediatric pertussis infection occurs after receipt of the second 
DTaP dose when examining overall risk through age six, although immediately following 
receipt of the first booster dose (4th dose overall) we observed a notable decrease in risk 
that became apparent when we restricted the study sample to a younger age group. These 
trends were not discernable in descriptive analysis (Table 13), but clearly emerged after 
covariate adjustment for confounding (Table 17).  
Overall, differing measures of vaccination uptake all reached the same 
conclusion: vaccination confers protection against pertussis, as has been widely reported 
in the literature.38,40,42,44,48,49 Yet this study contributes an important addition to the field: 
not only does being UTD for a given age lower pertussis risk, but increasing number of 
doses appears to lower risk, corroborating the current immunization schedule’s front-
loading of vaccination in infants. While studies have examined the notion of delayed (or 
early) vaccination,43,44,48 we included the additional concept of the number of childhood 
pertussis doses received and observed that a second dose additionally lowered risk 
overall, with a fourth (booster) dose offering immediate additional protection in the 
younger children. Corroborated by several randomized controlled trials of the acellular 
pertussis vaccine efficacy, the third dose may only marginally increase protection after 
the second dose.112,113 The finding of delayed UTD children being at an apparent lower 
risk of reported disease compared to on-time UTD children was likely produced by small 
cell counts, since testing reduction of disease incidence among on-time UTD versus 
delayed UTD when compared with children being not UTD did not reach significance. 
In addition to our major findings concerning measures of vaccine coverage and 
pertussis incidence, demographics impacted pertussis risk. Relative to white race, being 
	  	  
 
73	  
black or of other race lowered the risk of reported incident disease, while not being the 
first-born increased the risk of pertussis. The finding of black children being at reduced 
risk of pertussis relative to white children has been observed elsewhere.114,115 CDC 
surveillance data from 2012 indicates that while 13.4 cases per 100,000 people were 
reported in whites, only 4.1 cases per 100,000 people were reported in blacks. For other 
races (predominantly Asian in our sample) there were 3.7 reported cases per 100,000 
people. One posited reason for this was the passive nature of national surveillance. There 
may also be detection bias occurring, where white children are more likely to be 
diagnosed, as has been seen for other childhood diseases.116 Maternal parity, used here as 
a proxy for household size, was a borderline predictor of pertussis incidence and is likely 
the result of later birth order and larger family size associated with lower vaccination 
coverage.12,63,65,66,75,78,79 
Child’s age was strongly associated with disease risk, which became apparent 
when decomposed from the vaccination measure (i.e., cumulative number of doses). In 
our study sample, older children were at increased risk of pertussis. This finding may 
appear contradictory to national rates of pertussis being highest in infants less than one 
year of age.114 One possible reason may be an increased number of pathogen exposures 
for the older children in our population, for example from being in day care. While we 
were unable to ascertain whether in fact older children were more likely to be in day care, 
it has been observed elsewhere that despite high vaccination coverage, close contact in 
congregant settings is a risk factor for pertussis transmission.49 A second reason may be a 
waning immunity effect in the older children,17 however the “time since last dose” 
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variable was not predictive of pertussis in this population, likely due to the overall 
younger age. 
There were limitations to this study. First, reporting of pertussis in Philadelphia is 
a passive system that captures only reported potential cases, resulting in an 
underestimation in the number of cases. If the unreported cases had fewer vaccinations, 
the magnitude of association may also be underestimated in this analysis. Second, due to 
the time periods examined in this study, there may be population migration. For example, 
if families were likely to in-migrate because of availability of vaccination, and these 
children were at higher risk for pertussis, the odds ratio could also be underestimated. 
Third, as vaccination data were derived from the citywide immunization information 
system, the records are subject to the same limitations that any IIS is subject to, namely 
the records are incorrect or incomplete.105 Based on the experience of the PDPH, KIDS 
Plus IIS captures the majority of vaccinations and is regularly validated by nursing staff 
who visit clinics to ensure vaccination records are complete. Last, while the goal of this 
study was to guide other researchers in their choice of a vaccination uptake measure, the 
results may be specific to pertussis in Philadelphia, although every effort was made to 
guard against a selection bias that could affect generalizability. Study strengths include 
being a population-based study, large sample size, minimal missing data, and the ability 
to classify vaccination status in multiple ways. 
In summary, we observed a marked reduction in the risk of pertussis attributable 
to vaccination. For public health surveillance, the standard practice of classifying 
vaccination status as being UTD may not be as useful as examining the number of 
individual doses when assessing the risk for infection. For the pediatrician, our data 
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suggest that practitioners should redouble efforts for completion of the vaccine series in 
younger children, as is reflected in our findings for our study sample. 
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3.6. Tables and Figures 
Table 10. Determining on-time and delayed receipt of DTaP using 2013 CDC/ACIP 
birth-18yo schedule. 
Dose 
# 
ACIP 
recommended age 
Minimum 
acceptable age 
(wks) 
Maximum 
acceptable age 
(wks) 
Minimum acceptable 
interval from previous dose 
(wks) 
1 2 mos 6 13 -- 
2 4 mos 13 22 4 
3 6 mos 22 30 4 
4 15 – 18 mos 52 83 26 
5* 4 – 6 yrs 209 313 26 
*5th dose is unnecessary if 4th dose was administered at 4 yrs (209 wks) of age or older. 
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Table 11. Individual modeling approach. 
Model Type Outcome 
(Level) 
Covariates Meaning 
UTD 
(crude) 
Logistic Pertussis UTD Unadjusted pertussis OR by UTD 
status 
UTD (full) Logistic Pertussis UTD and all covariates from 
Figure 8 
Adjusted pertussis OR by UTD 
status 
Delayed 
(crude) 
Logistic Pertussis Delayed UTD Unadjusted pertussis OR by 
Delayed UTD status 
Delayed 
(full) 
Logistic Pertussis Delayed UTD and all 
covariates from Figure 8 
Adjusted pertussis OR by Delayed 
UTD status 
Doses 
(crude) 
Logistic Pertussis Categorical number of doses  Unadjusted pertussis OR by 
number of vaccination doses 
Doses 
(full) 
Logistic Pertussis Categorical number of doses 
and all covariates from 
Figure 8 
Adjusted pertussis OR by number 
of vaccination doses 
Trend 
(crude) 
Logistic Pertussis Continuous number of doses Unadjusted pertussis OR by 
number of vaccination doses, 
trend estimation 
Trend 
(full) 
Logistic Pertussis Continuous number of doses 
and all covariates from 
Figure 8 
Adjusted pertussis OR by number 
of vaccination doses, trend 
estimation 
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Table 12. Power and sample size estimates. 
N total N cases N controls NUTD OR of pertussis Power (95% simulation interval) 
500 250 250 3.00 99.2% (98.6%, 99.8%) 
1000 250 750 3.00 100% (100%, 100%) 
1500 500 1000 3.00 100% (100%, 100%) 
2000 500 1500 3.00 100% (100%, 100%) 
2500 500 2000 3.00 100% (100%, 100%) 
500 250 250 2.00 81.5% (79.1%, 83.9%) 
1000 250 750 2.00 98.7% (98.0%, 99.4%) 
1500 500 1000 2.00 99.8% (99.5%, 100%) 
2000 500 1500 2.00 100% (100%, 100%) 
2500 500 2000 2.00 100% (100%, 100%) 
500 250 250 1.50 40.0% (37.0%, 43.0%) 
1000 250 750 1.50 65.6% (62.7%, 68.5%) 
1500 500 1000 1.50 83.8% (81.5%, 86.1%) 
2000 500 1500 1.50 94.4% (93.0%, 95.8%) 
2500 500 2000 1.50 96.6% (95.5%, 97.7%) 
500 250 250 1.25 16.1% (13.8%, 18.4%) 
1000 250 750 1.25 25.3% (22.6%, 28.0%) 
1500 500 1000 1.25 37.2% (34.2%, 40.2%) 
2000 500 1500 1.25 49.8% (46.7%, 52.9%) 
2500 500 2000 1.25 56.2% (53.1%, 59.3%) 
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Table 13. Vaccination characteristics of study sample and comparison of cases and 
controls. 
 Characteristic Cases (n=235) Controls (n=940) All (n=1175) P-valuea 
Vaccination measure     
 Total (any vaccination) 14.9 (9.7) 16.0 (7.3) 15.7 (7.8) 0.03 
 Total (DTaP vaccination) 2.1 (1.7) 2.6 (1.5) 2.5 (1.5) <0.01 
  0 doses 49 (20.9) 55 (5.9) 104 (8.9) <0.01 
  1 dose 71 (30.2) 268 (28.5) 339 (28.9) 0.61 
  2 doses 17 (7.2) 132 (14.0) 149 (12.7) 0.01 
  3 doses 33 (14.0) 156 (16.6) 189 (16.1) 0.34 
  4 doses 47 (20.0) 246 (26.2) 293 (24.9) 0.05 
  5+ doses 18 (7.7) 83 (8.8) 101 (8.6) 0.57 
 Up-to-date (UTD) (n=1143)    <0.01 
  Not UTD 84 (35.9) 179 (19.7) 263 (23.0)  
  UTD 150 (64.1) 730 (80.3) 880 (77.0)  
 Delayed (n=1143)    <0.01 
  Not UTD 84 (35.9) 179 (19.7) 263 (23.0)  
  Delayed UTD 26 (11.1) 188 (20.7) 214 (18.7)  
  On time UTD 124 (53.0) 542 (59.6) 666 (58.3)  
 Time since last DTaP dose, wks 44.8 (53.6) 43.3 (52.7) 43.6 (52.8) 0.65 
Mean (standard deviation) for continuous measures; N (percent) for categorical measures; UTD, Up-to-
date. 
a Significance testing comparing cases and controls. 
  
	  	  
 
80	  
Table 14. Sociodemographic characteristics of study sample and comparison of 
cases and controls. 
 Characteristic Cases (n=235) Controls (n=940) All (n=1175) P-valuea 
Child demographics     
 Age, yrsb    0.93 
  <1 115 (48.9) 463 (49.3) 578 (49.2)  
  >=1 120 (51.1) 477 (50.7) 597 (50.8)  
 Gender    0.05 
  Female 134 (57.0) 469 (49.9) 603 (51.3)  
  Male 101 (43.0) 471 (50.1) 572 (48.7)  
 Race (n=1102)    <0.01 
  White 83 (41.7) 265 (29.3) 348 (31.6)  
  Black 93 (46.7) 500 (55.4) 593 (53.8)  
  Other 23 (11.6) 138 (15.3) 161 (14.6)  
 Ethnicity (n=1100)    0.04 
  Non-Hispanic 159 (78.7) 761 (84.7) 920 (83.6)  
  Hispanic 43 (21.3) 137 (15.3) 180 (16.4)  
Maternal sociodemographics     
 Age, yrs (n=1131) 28.4 (7.2) 28.6 (6.7) 28.5 (6.8) 0.81 
 Marital status (n=1130)    0.25 
  Not married 122 (59.2) 587 (63.5) 709 (62.7)  
  Married 84 (40.8) 337 (36.5) 421 (37.3)  
 Nativity (n=1055)    <0.01 
  U.S. born 170 (90.4) 698 (80.5) 868 (82.3)  
  Foreign born 18 (9.6) 169 (19.5) 187 (17.7)  
 Education (n=1112)    0.73 
  No high school diploma 42 (20.9) 212 (23.3) 254 (22.8)  
  High school diploma/GED 71 (35.3) 303 (33.3) 374 (33.6)  
  College or higher 88 (43.8) 396 (43.5) 484 (43.5)  
 Insurance at birth (n=862)    0.94 
  No private insurance 89 (55.6) 388 (55.3) 477 (55.3)  
  Private insurance 71 (44.4) 314 (44.7) 385 (44.7)  
 Parity (n=1113)    0.12 
  Primiparous 71 (35.1) 374 (41.1) 445 (40.0)  
  Multiparous 131 (64.9) 537 (58.9) 668 (60.0)  
Mean (standard deviation) for continuous measures; N (percent) for categorical measures; UTD, Up-to-
date. 
a Significance testing comparing cases and controls. 
b Frequency matched between cases and controls. 
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Table 15. Comparison of up-to-date vaccination status of the study sample (n=1143). 
 Characteristic UTD (n=880) Not UTD (n=263) P-valuea 
Child demographics    
 Age, yrs   0.01 
  <1 410 (46.6) 146 (55.5)  
  >=1 470 (53.4) 117 (44.5)  
 Gender   0.75 
  Female 455 (51.7) 133 (50.6)  
  Male 425 (48.3) 130 (49.4)  
 Race (n=1070)   0.37 
  White 269 (32.4) 269 (32.4)  
  Black 138 (57.7) 439 (52.8)  
  Other 34 (14.2) 123 (14.8)  
 Ethnicity (n=1069)   0.94 
  Non-Hispanic 697 (83.8) 199 (84.0)  
  Hispanic 135 (16.2) 38 (16.0)  
Maternal sociodemographics    
 Age, yrs (n=1099) 28.2 (6.6) 28.6 (6.8) 0.33 
 Marital status (n=1098)   0.36 
  Not married 529 (61.9) 159 (65.2)  
  Married 325 (38.1) 85 (34.8)  
 Nativity (n=1024)   0.48 
  U.S. born 659 (82.6) 182 (80.5)  
  Foreign born 139 (17.4) 44 (19.5)  
 Education (n=1081)   0.33 
  No high school diploma 188 (22.3) 58 (24.4)  
  High school diploma/GED 280 (33.2) 87 (36.6)  
  College or higher 375 (44.5) 93 (39.1)  
 Insurance at birth (n=842)   0.01 
  No private insurance 352 (53.2) 115 (63.9)  
  Private insurance 310 (46.8) 65 (36.1)  
 Parity (n=1081)   <0.01 
  Primiparous 365 (43.3) 69 (28.9)  
  Multiparous 477 (56.7) 170 (71.1)  
Mean (standard deviation) for continuous measures; N (percent) for categorical measures; UTD, Up-to-
date. 
a Significance testing comparing UTD and not UTD. 
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Table 16. Comparison of key characteristics by missingness of the study sample 
(n=1175). 
 Characteristic Complete (n=1036) Missinga (n=139) P-valueb 
Child demographics    
 Age, yrs   0.95 
  <1 510 (49.2) 68 (48.9)  
  >=1 526 (50.8) 71 (51.1)  
 Gender   0.31 
  Female 526 (50.8) 77 (55.4)  
  Male 510 (49.2) 62 (44.6)  
 Race (n=1102)   0.12 
  White 326 (31.5) 22 (33.3)  
  Black 553 (53.4) 40 (60.6)  
  Other 157 (15.2) 4 (6.1)  
 Ethnicity (n=1100)   <0.01 
  Non-Hispanic 857 (85.1) 63 (67.7)  
  Hispanic 150 (14.9) 30 (32.3)  
Maternal sociodemographics    
 Age, yrs (n=1131) 28.6 (6.8) 28.2 (6.8) 0.61 
 Marital status (n=1130)   0.80 
  Not married 647 (62.6) 62 (63.9)  
  Married 386 (37.4) 35 (36.1)  
 Nativity (n=1055)   0.32 
  U.S. born 799 (82.6) 69 (78.4)  
  Foreign born 168 (17.4) 19 (21.6)  
 Education (n=1112)   0.15 
  No high school diploma 227 (22.3) 27 (29.3)  
  High school diploma/GED 341 (33.4) 33 (35.9)  
  College or higher 452 (44.3) 32 (34.8)  
 Insurance at birth (n=863)   0.08 
  No private insurance 433 (54.5) 44 (65.7)  
  Private insurance 362 (45.5) 23 (34.3)  
 Parity (n=1113)   0.25 
  Primiparous 419 (40.4) 26 (33.8)  
  Multiparous 617 (59.6) 51 (66.2)  
Mean (standard deviation) for continuous measures; N (percent) for categorical measures. 
a Missing on regression parameters: child age, child race, maternal parity, and vaccination measure. 
b Significance testing comparing those with complete data and those with missing data. 
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Table 17. Odds ratios, 95% confidence intervals, and diagnostics for vaccination 
coverage models predicting reported pertussis incidence, adjusted for demographics 
and maternal parity. 
 
UTD, Up-to-date; AIC, Akaike Information Criterion; BIC, Bayesian Information Criterion. 
* p<0.05,  ** p<0.01,  *** p<0.001 
a Bootstrap mean AIC/BIC and 95% confidence intervals; lower value indicates better model fit. 
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Figure 7. Hypothetical vaccination statuses of four children aged 2 yrs evaluated per 
2013 CDC/ACIP birth-18yo schedule for Diphtheria, Tetanus, and acellular 
Pertussis vaccine. 
 
UTD, Up-to-date. 
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Figure 8. Conceptual diagram of etiologic pathway. 
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Figure 9. Mean change in vaccine effectiveness with corresponding 95% confidence 
intervals for the fourth dose of DTaP observed when restricting the study sample by 
maximum age. 
 
VE, vaccine effectiveness; DTaP, Diphtheria, Tetanus, acellular Pertussis. 
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Figure 10. Mean AIC (a.) and BIC (b.) with corresponding 95% confidence intervals 
comparing vaccination coverage models. 
 
 
UTD, Up-to-date; AIC, Akaike Information Criterion; BIC, Bayesian Information Criterion; CI, confidence 
interval. Lower value indicates better model fit. Dashed line is for comparison to UTD as the reference 
model. 
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4. BAYESIAN CORRECTION of MISCLASSIFICATION of PERTUSSIS in 
VACCINE EFFECTIVNESS STUDIES: HOW MUCH does UNDERREPORTING 
MATTER? 
 
 
4.1. Abstract 
Background: Diagnosis of pertussis remains a challenge and consequently research on 
the risk of pertussis may be biased due to misclassification of the disease. We quantified 
misclassification and corrected for it in an analysis of vaccine effectiveness. 
Methods: A case-control study of children in Philadelphia aged three months through six 
years, diagnosed between 2011 and 2013. Vaccine effectiveness (1 – odds ratio) was used 
to describe the association between being up-to-date on pertussis-antigen containing 
vaccines and reported incident cases of pertussis. Bayesian techniques were used to 
correct for purported non-differential misclassification by reclassifying the cases per the 
2014 Council of State and Territorial Epidemiologists pertussis case definition. 
Results: Naïve vaccine effectiveness was 50% (95% CI: 16%, 69%). After correcting for 
misclassification, vaccine effectiveness ranged from 57% (95% CrI: 30%, 73%) to 82% 
(95% CrI: 43%, 95%) depending on the amount of underreporting of pertussis assumed to 
have occurred in the study period. Meaningful misclassification was observed in terms of 
false negatives detected after the incorporation of infant apnea to the 2014 case 
definition. While specificity was nearly perfect, sensitivity of the case definition varied 
from 90% to 20% depending on the assumption about missed cases. 
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Conclusion: We observed meaningful non-differential misclassification of pertussis that 
attenuated the true measure of pertussis vaccine effectiveness. Knowing the degree of the 
underreporting is essential to accurate evaluation of vaccine effectiveness.  
 
4.2. Introduction 
 Pertussis remains an endemic disease in the United States, and despite 
standardized case definitions, it is still difficult to diagnosis given its resemblance to 
other respiratory diseases.117 Diagnosis of pertussis includes clinical components, such as 
sustained cough, inspiratory “whoop”, and posttussive vomiting; laboratory components, 
such as isolation of the Bordatella pertussis bacterial organism or polymerase chain 
reaction (PCR) detection of its DNA; and epidemiological components, like contact with 
a lab-confirmed case. The specific case definition of pertussis takes these various 
components into account to classify a probable or confirmed case, and varies for endemic 
and sporadic versus outbreak settings. 
 These case definitions are published as position statements by the Council of State 
and Territorial Epidemiologists and endorsed by the Centers for Disease Control and 
Prevention.118 For a disease like pertussis, the case definitions have changed over time; 
for example to incorporate newer diagnostic technologies like PCR, or to incorporate 
distinguishing disease features like apnea in infants (Table 18).119,120,121 A study 
conducted before the most recent iteration of the case definition found over 10% of 
individuals with a positive PCR did not meet the clinical component for diagnoses, with 
recommendations including adding apnea as a criteria and reducing cough duration from 
two weeks to one.122 Even with infant apnea included in the 2014 definition, the lack of a 
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shorter cough duration still means some positives PCR tests may not be classified as 
pertussis, which translates to imperfect sensitivity (SN). However, there may also be low 
specificity (SP) of the case definition. A 2010 study conducted among school-age 
children with an unspecified cough of at least two weeks duration applied the World 
Health Organization (WHO) definition of pertussis and noted 15% SP using the WHO 
criteria compared to PCR as the gold standard, while SN was >95%.123 In short, 
regardless of the definition, there is the possibility of misclassification of pertussis. 
 Misclassification may also occur from the changing case definition. For example, 
a hypothetical case-control study that spans 2013 and 2014 may have pertussis cases 
classified according to two separate definitions, one that includes infant apnea, and one 
that does not. Studies that span longer time frames can include even more definitions, 
therefore in retrospective studies that examine pertussis as the outcome results may be 
biased. 
One possible remedy of this misclassification is to case-classify all potential cases 
according to a single definition if clinical and laboratory data are available. When this is 
not possible, statistical techniques can be invoked if there is some knowledge about the 
source(s) of misclassification.124,125 Regardless of the technique, a sense of the magnitude 
of misclassification is necessary to account for it in data analysis and interpretation. 
The current study is initially aimed at providing a sense of misclassification of 
pertussis in an urban population of children, and secondly demonstrating the impact made 
on vaccine effectiveness (VE) measures when applying statistical methods to correct for 
it. We focused on reported incident cases of pediatric pertussis in Philadelphia, PA. This 
disease is of particular interest as there has been a sharp increase in cases over recent 
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years, both locally and nationally, and in fact in 2012 Philadelphia experienced twice as 
many cases as in the previous year.34 
 
4.3. Methods 
4.3.1. Source Population and Study Sample 
The source population for this study was children born in Philadelphia between 1-
Jan-2005 and 31-Dec-2013 who were registered in KIDS Plus, the city’s immunization 
information system (IIS). The KIDS Plus IIS represents an open cohort of children who 
were born in Philadelphia or who received vaccinations from Philadelphia-based 
providers and it was used to derive the study sample of both incident pertussis cases and 
controls for a nested case-control analysis. Potential pertussis cases that occurred between 
1-Jan-2011 and 31-Dec-2013 were reported to the PDPH as mandated by the Philadelphia 
Health Code.22 Controls were selected using incidence density sampling from non-case 
children in KIDS Plus IIS at a 4:1 control-to-case ratio and frequency matched by date of 
birth to within two weeks. The study sample was restricted to children aged three months 
through six years to capture the opportunity of receiving the full five-dose series of 
pertussis vaccine in childhood. Given the very high pediatric vaccination rates in 
Philadelphia, children with fewer than two vaccines (any type) were excluded as these 
children were considered born in Philadelphia but moved or resided elsewhere. This 
study was approved by the Institutional Review Boards for the City of Philadelphia and 
Drexel University (Philadelphia, PA). 
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4.3.2. Variable Selection 
Vaccination data included all pertussis antigen-containing vaccinations (i.e., 
Diphtheria, Tetanus, acellular Pertussis) through the child’s age as of the case diagnosis 
date (or matched case date for controls). Doses administered within two weeks of each 
other were considered duplicates and the later dose discarded. Using the 2013 CDC/ACIP 
schedule (see Appendix A: Vaccination Schedules) there were five recommended doses of 
DTaP by age six.13 The primary exposure for this study was vaccination status 
operationalized as being up-to-date (UTD) on vaccinations, which was considered met if 
and only if a child received all vaccinations recommended for his or her age group by 
their study age. 
The outcome under study was reported incident cases of confirmed or probable 
pertussis, defined by the Council of State and Territorial Epidemiologists (CSTE) as a 
cough illness, without other apparent causes, lasting at least two weeks, with one or more 
of these clinical indicators: paroxysms of coughing, inspiratory "whoop," or posttussive 
vomiting. According to the CSTE, confirmed cases required positive laboratory 
diagnostics or epidemiological linkage (contact) to a lab-confirmed case. Probable cases 
fit the clinical criteria, but were either not confirmed by laboratory findings or were not 
epidemiologically linked to another case. 
The 1997/2010 CSTE pertussis case definition119,120 was used at the time of the 
reported potential case for initial case determination. However, as the case definition has 
recently changed we applied the 2014 CSTE definition, which adds separate infant 
diagnostic criteria,121 to the potentially misclassified reported cases and treated this as our 
gold standard case classification. The authors recognize that in other settings the original 
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diagnostic criteria may not be available historically. To simulate this “what-if” scenario, 
we blinded ourselves to the reclassified case status during the Bayesian analysis, and 
assumed only the original (misclassified) case status was known. 
In addition to the primary exposure and outcome, several covariates were 
considered as potential confounders (Figure 11) including maternal age, maternal marital 
status (married, not married), race (black, non-black), ethnicity (Hispanic, non-Hispanic), 
maternal nativity (U.S. born, foreign born), child age (<1yr, >=1yr), child sex, maternal 
education (no high school diploma, high school diploma or GED, college and higher), 
maternal insurance status as time of birth (private insurance, no private insurance), and 
maternal parity (primiparous, multiparous). Covariates were adjusted in regression 
modeling if they were associated with both the exposure and outcome (p < 0.20), or if 
they changed this relationship by > 10%.98 All covariate data were imported from KIDS 
Plus IIS and Pennsylvania Department of Health Vital Statistics records. 
 
4.3.3. Statistical Analysis 
We chose to correct for non-differential outcome misclassification adapting the 
exposure misclassification approaches of Gustafson126 and Luta et al.127 via three models.  
Eq.1, the outcome model, specifies the log odds of true pertussis (Case=1) given one’s 
UTD status, adjusted for potential confounding:  
logit{r=Pr(Case=1)} = β0 + β1UTD + β2Age + β3Race + β4Multiparous 
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Eq. 2, the measurement model, relates the imperfect apparent measure of pertussis 
(Case*=1) to the conditional probability of true pertussis status accounting for the 
believed degree of misclassification: 
Pr(Case *=1) =  r(SN) + (1 – r)(1 – SP) 
 
Eq. 3, the exposure model, specifies the log odds of being UTD given the exposure 
predictors: 
 logit{Pr(UTD=1)} = α0 + α1Age + α2Race + α3Multiparous 
 
In order to implement the analysis in the Bayesian framework, we needed to 
define the statistical distributions of parameters and prior probabilities. In the outcome 
and exposure models (Eqs. 1 and 3), we used independent non-informative Gaussian 
priors (mean=0, variance=10) for the intercepts and covariates (β0, β2 – β4, α0 – α3). For 
the log odds of pertussis (β1), we consulted an external VE study on the association 
between DTaP UTD status and pertussis128 and set the mean equivalent to the log odds of 
the reported 83% VE and the variance to 0.5, corresponding to a 95% confidence the true 
VE lies between 32% and 96%, yielding the prior ~ Normal(log(1-0.83),0.5).  
To express SN and SP in the measurement model (Eq. 2) as prior distributions 
required us to express the number of reported and unreported cases (Figure 12). We let A 
represent the reported potential cases that were classified as true cases by the Health 
Department and the 2014 case definition, and B represent the reported cases that were 
classified as true cases by the Health Department but did not satisfy the criteria of the 
2014 case definition (false positives). Similarly, we let D represent the reported potential 
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cases that were classified as non-cases per the Health Department and 2014 case 
definition, and C represent the reported cases that were classified as non-cases per the 
Health Department yet satisfied the criteria of the 2014 case definition (false negatives). 
Among the remaining population of children in Philadelphia, we assumed some 
proportion are infected with pertussis, and therefore let E represent the number of 
unreported cases that would have been classified as true cases per the 2014 case 
definition (false negatives in the population). Finally, we let F represent the number of 
unreported non-cases (true negatives in the population). The values of the SN and SP 
priors were expressed as Beta distributions that combined both validation data and expert 
opinion,127 as follows: for SN, Beta(A,C+E); and for SP, Beta(D+F,B). It is crucial to 
note that we did not have any information about E, except that it (a) must be much 
smaller than the number of children at risk (pertussis is rare), (b) is unlikely to be as large 
as the number of reported potential cases to the Health Department, and (c) it is not 
possible to assert that all cases were captured, therefore E>0. With these considerations in 
mind, we conducted sensitivity analyses by varying values of E over the range from 0 to 
500, recognizing the boundaries of this range are likely unrealistic. 
Using MLPowSim (University of Bristol, Bristol, UK) we estimated power for 
different sample sizes, magnitudes of association, and variations in the data. We assumed 
a fixed alpha of 5%, a desired beta of 20% (80% power), a prevalence of UTD of 85%†, 
and ran 1000 simulations of the estimating model at a step size of 500 individuals (range 
500 to 2500). The estimating model represented the relationship between being UTD (the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
† 85% prevalence of UTD on 4-DTaPs based on the CDC National Immunization Survey 
(NIS) - Children (19-35 months) for Philadelphia County, various years.  
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independent variable) and reported incident pertussis (the dependent variable). Results 
are shown in Table 19.  
Analyses were conducted using SAS 9.2 (SAS Institute Inc., Cary, NC) and R 
3.1.0 (R Foundation for Statistical Computing, Vienna, Austria). Measures of risk were 
estimated as odds ratios (OR), which given the low prevalence of pertussis in this 
population, approximates the relative risk. Vaccine effectiveness (VE) was defined as 1 – 
OR. Precision estimates are provided as 95% confidence intervals (CI) and 95% credible 
intervals (CrI), as well as confidence/credible limit ratios (CIR/CrIR) to facilitate 
comparisons.129 Bayesian inference was performed via Markov chain Monte Carlo 
simulation using JAGS (Just Another Gibbs Sampler) via the rjags package (Plummer M, 
Bayesian graphical models using MCMC, 2014), version 3-13. We drew 20,000 samples 
from the posterior distributions using two chains, and discarded the first 1,000 
observations for burn-in. Model convergence was ascertained via parameter sampling 
history and Gelman and Rubin's convergence diagnostic (Figures 13 – 16). Annotated R 
code is available in Appendix F: BUGS Model Specification for Bayesian Inference via 
JAGS in R. 
 
4.4. Results 
4.4.1. Characteristics of Case Control Sample 
The sample yielded 811 children aged three months through six years, including 
355 reported potential pertussis cases and 456 non-reported controls, summarized in 
Table 20. Overall, 79% of this population was UTD on their pertussis vaccinations. The 
imperfect apparent Health Department case classification was used to decompose the 355 
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reported cases into confirmed and probable cases (n=114) and reported controls with 
pertussis-like symptoms (n=241). Compared to the non-reported controls, more cases 
were non-black (58% vs. 46%), Hispanic (25% vs. 15%), and not UTD on their DTaP 
vaccinations (34% vs. 17%). When comparing the non-reported and reported controls, 
they did not differ by UTD status (83% vs. 79%, respectively) thereby reducing risk of 
substantial selection bias; although compared to the non-reported controls, reported 
controls were older (88% vs. 61% aged one or older) and from mothers with less formal 
education (30% vs. 21% without a high school diploma). 
For the regression modeling, child age and race, and maternal parity were 
included as potential confounders. Missingness on these three variables was about 15%, 
therefore we present a complete case analysis. To ensure the missing data on these three 
variables, as well as vaccination history, did not threaten internal validity, we stratified 
the study participant characteristics by a missing data indicator (Table 21). Interestingly, 
we noted older children (p=0.01), black race (p=0.03), Hispanic ethnicity (p<0.01), and 
lower maternal education (p=0.03) were associated with missing data. 
 
4.4.2. Prior Specification: Sensitivity and Specificity of Case Classification 
As of the 2010 U.S. Census, there was approximately 120,000 children aged birth 
through six residing in Philadelphia, of which 355 were reported to the Health 
Department as potential pertussis cases, leaving 119,645 who were not reported to the 
Health Department (Table 22). Based on the gold standard 2014 case definition, 113 were 
correctly identified by the Health Department as true cases with 1 false positive, and 228 
were correctly identified as true non-cases with 13 false negatives. If we assume perfect 
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reporting of cases (E=0, no underreporting), this corresponds to 90% SN and near perfect 
SP. Relaxing this assumption by varying amounts (E=5, 50, and 500 unreported cases) 
reduced the SN accordingly: 86%, 64%, 18%, respectively. 
As we had validation data, and deemed expert opinion unnecessary, all 
distributions were combined with Beta(1,1) as recommended,127 yielding the following 
sets of priors: SNE=0~Beta(113,13), SPE=0~Beta(119873,1); SNE=5~Beta(113,18), 
SPE=5~Beta(119868,1); SNE=50~Beta(113,63), SPE=50~Beta(119823,1); 
SNE=500~Beta(113,513), SPE=500~Beta(119373,1). 
 
4.4.3. Bayesian Misclassification Correction 
 We first estimated the biased DTaP VE for pertussis using the imperfect apparent 
case classification by the Health Department. This estimate serves as the basis for 
comparison. On average, the DTaP vaccine effectiveness for children who were UTD 
was 50% (95% CI: 16%, 69%). As shown in Table 23, after correcting for 
misclassification, the VE improved to 57% (95% CrI: 30%, 73%) if we assume no 
underreporting with a corresponding increase in precision, indicating Bayesian learning. 
Compared to the strong assumption of perfect reporting of cases, the VE slightly 
improved when the number of unreported cases remained low (VE=58% and 61% for 5 
and 50 unreported cases). Under unrealistic underreporting of 500 cases of pertussis, the 
naïve VE was substantially underestimated. 
 Table 24 provides an idea of the observed misclassification. SN was high when 
there were few unreported cases (relative to reported cases), and declined as the number 
of unreported cases increased, indicating greater presence of false negatives. SP remained 
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near perfect, as once cases were classified as pertussis by the Health Department, they 
likely remained so under the 2014 case definition. 
 
4.5. Discussion 
In this retrospective analysis of childhood pertussis in Philadelphia, we quantified 
the amount of misclassification present when cases of disease are not re-classified based 
on current case definitions. With the addition of infant apnea to the clinical criteria in 
2014, otherwise negative cases should have become positive cases,122 indicating 
meaningful misclassification that underestimated DTaP vaccine effectiveness in children 
aged three months through six years. We also analyzed how underreporting of diseases 
may further bias vaccine effectiveness. 
We took the perspective of examining the case definition of pertussis as applied to 
the population of children in Philadelphia. From this perspective, we were able to 
describe the performance of passive surveillance in capturing the population of pediatric 
pertussis, and further consider pertussis cases that are not reported to the Health 
Department, modeled by adding uncertainty to the prior distributions for sensitivity. As a 
result of applying the case definition in the general population representing reported and 
unreported cases, our estimates of SN and SP are not comparable to earlier studies that 
considered SN and SP conditioned on being symptomatic.122,123  
Underreporting of pertussis is a recognized problem with passive surveillance. A 
study by Dominguez et al. comparing passive to enhanced surveillance noted that while 
passive surveillance was generally robust in capturing pertussis cases in infants less than 
one year of age (96% of cases detected), it declined in older children (60% detection in 
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children aged one through four, and 68% in children aged five through ten).130 Another 
study conducted in Spain examined reported versus hospitalized cases of pertussis among 
children between 1997 and 2010 and found overall underreporting ranged from 4-23%, 
depending on the year, with the greatest disparity in reporting for infants less than one 
year of age.131 To supplement passive surveillance, there have been general calls for 
enhanced and active surveillance for pertussis.130,131,132,133 It is notable that in our 
analysis, the degree of underreporting that was in the plausible range of 5 to 50 cases 
over the study period did not materially change the estimate of vaccine effectiveness. 
This could not have been anticipated before the calculations were performed, and boosted 
our confidence that with approximately 95% certainty true vaccine effectiveness in this 
study comparing UTD to not UTD children was between 30 and 80%. 
To our knowledge this is the first study to quantify misclassification of pertussis 
due to a changing case definition; however previous work has examined the changing 
case definition of other notifiable diseases, notably AIDS. Effected in January 1993, the 
CDC revised the case definition of AIDS for surveillance in the United States,134 and 
observed a doubling in incidence that year mainly due to the new threshold for CD4 T 
lymphocytes.135 Previously false negatives were included, thereby improving sensitivity 
of the definition. In fact, one group of researchers applied Bayesian calculations to 
estimate the change in new cases, and predicted the doubling of incidence.136 These 
results were quite dramatic considering the scope of the surveillance and marked changed 
in the definition.  
Our work is subject to several limitations. First, due to the time periods examined 
in this study, there may be population migration. For example, if families were likely to 
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in-migrate because of availability of vaccination, and these children were at higher risk 
for pertussis, the odds ratio could also be underestimated. Second, as vaccination data 
were derived from the citywide immunization information system, the records are subject 
to the same limitations of any IIS, namely the records are incorrect or incomplete.105 
Based on the experience of the PDPH, KIDS Plus IIS captures the majority of 
vaccinations and is regularly validated by nursing staff who visit clinics to ensure 
vaccination records are complete. Third, for simplicity, this analysis treated the 
misclassification as non-differential. It is possible that varying degrees of underreporting 
by age resulted in differential misclassification. Lastly, we assumed proper prior 
specification in the Bayesian analysis, including perfect classification of the covariates 
and exposure. Priors may have strong influence on the posterior distributions, and if the 
validation study does not accurately represent the same population, may bias the present 
analysis. Adding statistical uncertainty to the prior (increasing the variance) can help 
mitigate this occurrence. The study strengths include being a population-based study, 
large sample size, minimal missing data, and use of a Bayesian framework that readily 
allowed flexible incorporation of useful prior knowledge including unreported cases. 
In summary, this analysis indicates that in naïve retrospective studies of vaccine 
uptake and pertussis, the magnitude of the association may be attenuated by disease 
misclassification. Therefore, we recommend that either case classification get re-applied 
by the investigator, or if data are unavailable, to use the validation data herein to perform 
a quantitative bias adjustment. Underreporting of cases may be of considerable 
importance in similar analyses: relying on the assumption that all true cases were 
reported to the Health Department (i.e., perfect sensitivity of the surveillance program) 
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can lead to substantial bias if the assumption is wrong. Although our disease of interest 
was pertussis, this analysis can readily be applied to any disease where misclassification 
is suspect in surveillance data, with an eye towards ultimately improving surveillance. 
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4.6. Tables and Figures 
Table 18. Comparison of CSTE pertussis diagnostic criteria for confirmed cases: 
January 1995 – January 2014. 
 Diagnostic criteriaa 1995 1996 1997b 2014c 
Clinical     
 2-week cough illness w/ X X X X 
     Parxoysms of cough X X X X 
     Inspiratory “whoop” X X X X 
     Posttusive vomiting X X X X 
     Apnead    X 
Laboratory     
 Polymerase chain reaction (PCR)e  X X X 
 Isolation of B. pertussisf X X X X 
Epidemiological     
 Contact with lab-confirmed caseg X X X X 
CSTE, Council of State and Territorial Epidemiologists 
a Criteria are applicable under endemic/sporadic cases; in outbreak settings only 2-week cough illness may 
apply. 
b 1997 case definition is functionally equivalent to the 2010 case definition. 
c Used as the gold standard case definition in this analysis. 
c For infants <1 year of age. 
d Requires presence of clinical components (applies to positive PCR starting in 1997). 
e Isolation of the organism does not require additional diagnostic criteria. 
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Table 19. Power and sample size estimates. 
N total N cases N controls NUTD OR of pertussis Power (95% simulation interval) 
500 250 250 3.00 99.2% (98.6%, 99.8%) 
1000 250 750 3.00 100% (100%, 100%) 
1500 500 1000 3.00 100% (100%, 100%) 
2000 500 1500 3.00 100% (100%, 100%) 
2500 500 2000 3.00 100% (100%, 100%) 
500 250 250 2.00 81.5% (79.1%, 83.9%) 
1000 250 750 2.00 98.7% (98.0%, 99.4%) 
1500 500 1000 2.00 99.8% (99.5%, 100%) 
2000 500 1500 2.00 100% (100%, 100%) 
2500 500 2000 2.00 100% (100%, 100%) 
500 250 250 1.50 40.0% (37.0%, 43.0%) 
1000 250 750 1.50 65.6% (62.7%, 68.5%) 
1500 500 1000 1.50 83.8% (81.5%, 86.1%) 
2000 500 1500 1.50 94.4% (93.0%, 95.8%) 
2500 500 2000 1.50 96.6% (95.5%, 97.7%) 
500 250 250 1.25 16.1% (13.8%, 18.4%) 
1000 250 750 1.25 25.3% (22.6%, 28.0%) 
1500 500 1000 1.25 37.2% (34.2%, 40.2%) 
2000 500 1500 1.25 49.8% (46.7%, 52.9%) 
2500 500 2000 1.25 56.2% (53.1%, 59.3%) 
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Table 20. Characteristics of the study sample and comparison of imperfect apparent 
reported cases to controls. 
    Reported potential cases (n=355) 
 Characteristic Total 
(n=811) 
Non-reported 
controla 
(n=456) 
Confirmed or 
probable casea,b 
(n=114) 
Reported 
controla,b,c 
(n=241) 
Child demographics     
 Age, yrs     
  <1 558 (68.8) 179 (39.3) 44 (38.6) 30 (12.4)* 
  >=1 253 (31.2) 277 (60.7) 70 (61.4) 211 (87.6)* 
 Gender (n=800)     
  Female 428 (53.5) 229 (50.2) 68 (59.6) 131 (57.0) 
  Male 372 (46.5) 227 (49.8) 46 (40.4) 99 (43.0) 
 Race (n=719)     
  Non-black 341 (47.4) 204 (46.2) 56 (58.3)* 81 (44.8) 
  Black 378 (52.6) 238 (53.8) 40 (41.7)* 100 (55.2) 
 Ethnicity (n=722)     
  Non-Hispanic 599 (83.0) 371 (85.3) 72 (75.0)* 156 (81.7) 
  Hispanic 123 (17.0) 64 (14.7) 24 (25.0)* 35 (18.3) 
Maternal sociodemographics     
 Age, yrs (n=742) 29.3 (6.5) 29.1 (6.4) 29.7 (7.5) 29.7 (6.4) 
 Marital status (n=741)     
  Not married 469 (63.3) 283 (63.0) 65 (64.4) 121 (63.4) 
  Married 272 (36.7) 166 (37.0) 36 (35.6) 70 (36.6) 
 Nativity (n=687)     
  U.S. born 568 (82.7) 344 (81.1) 80 (87.0) 144 (84.2) 
  Foreign born 119 (17.3) 80 (18.9) 12 (13.0) 27 (15.8) 
 Education (n=735)     
  No high school diploma 172 (23.4) 92 (20.6) 24 (24.2) 56 (29.5)* 
  High school diploma/GED 226 (30.7) 139 (31.2) 28 (28.3) 59 (31.1)* 
  College or higher 337 (45.9) 215 (48.2) 47 (47.5) 75 (39.5)* 
 Insurance at birth (n=680)     
  No private insurance 390 (57.4) 239 (57.9) 53 (57.0) 98 (56.3) 
  Private insurance 290 (42.6) 174 (42.1) 40 (43.0) 76 (43.7) 
 Parity (n=736)     
  Primiparous 285 (38.7) 183 (41.1) 36 (35.6) 66 (34.7) 
  Multiparous 451 (61.3) 262 (58.9) 64 (64.4) 124 (65.3) 
Pertussis vaccinations     
 Up-to-date (UTD) (n=790)     
  Not UTD 163 (20.6) 74 (16.8) 39 (34.2)* 50 (21.3) 
  UTD 627 (79.4) 367 (83.2) 75 (65.8)* 185 (78.7) 
Mean (standard deviation) for continuous measures; N (percent) for categorical measures; UTD, Up-to-
date. 
* p<0.05. 
a Based on imperfect apparent Health Department classification of case status. 
b Significance testing compared to study controls. 
c Reported to the Health Department with pertussis-like symptoms.  
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Table 21. Comparison of key characteristics by missingness for the study sample 
(n=811). 
 Characteristic Complete (n=677) Missinga (n=134) P-valueb 
Child demographics    
 Age, yrs   0.01 
  <1 224 (33.1) 29 (21.6)  
  >=1 453 (66.9) 105 (78.4)  
 Gender (n=800)   0.45 
  Female 354 (52.9) 74 (56.5)  
  Male 315 (47.1) 57 (43.5)  
 Race (n=719)   0.03 
  Non-black 328 (48.4) 13 (31.0)  
  Black 349 (51.6) 29 (69.0)  
 Ethnicity (n=722)   <0.01 
  Non-Hispanic 565 (86.1) 34 (51.5)  
  Hispanic 91 (13.9) 32 (48.5)  
Maternal sociodemographics    
 Age, yrs (n=742) 29.4 (6.6) 29.1 (6.1) 0.75 
 Marital status (n=741)   0.55 
  Not married 425 (63.0) 44 (66.7)  
  Married 250 (37.0) 22 (33.3)  
 Nativity (n=687)   0.06 
  U.S. born 522 (83.5) 46 (74.2)  
  Foreign born 103 (16.5) 16 (25.8)  
 Education (n=735)   0.03 
  No high school diploma 149 (22.2) 23 (35.9)  
  High school diploma/GED 207 (30.8) 19 (29.7)  
  College or higher 315 (46.9) 22 (34.4)  
 Insurance at birth (n=680)   0.48 
  No private insurance 356 (57.0) 34 (61.8)  
  Private insurance 269 (43.0) 21 (38.2)  
 Parity (n=736)   0.18 
  Primiparous 267 (39.4) 18 (30.5)  
  Multiparous 410 (60.6) 41 (69.5)  
Mean (standard deviation) for continuous measures; N (percent) for categorical measures. 
a Missing on regression parameters: child age, child race, maternal parity, and vaccination measure. 
b Significance testing comparing those with complete data and those with missing data. 
  
	  	  
 
107	  
Table 22. Specification of the priors for sensitivity and specificity of pertussis case 
classification as Beta distributions assuming varying degrees of underreporting of 
pertussis. 
 Scenario #1 
(E=0) 
Scenario #2 
(E=5) 
Scenario #3 
(E=50) 
Scenario #4 
(E=500) 
Total populationa (A+B+C+D+E+F) 120,000 120,000 120,000 120,000 
Reported cases (A+B+C+D) 355 355 355 355 
   Confirmed or probable (A+B) 114 114 114 114 
   Symptomatic non-case (C+D) 241 241 241 241 
Case classificationb     
    True positives (A) 113 113 113 113 
    False positives (B) 1 1 1 1 
    False negatives (C) 13 13 13 13 
    True negatives (D) 228 228 228 228 
Not reported (E+F) 119,645 119,645 119,645 119,645 
    Non-cases (F) 119,645 119,640 119,595 119,145 
    Underreported cases (E) 0 5 50 500 
Sensitivity (A/[A+C+E]) 0.90 0.86 0.64 0.18 
    Beta distribution (A, C+E) (113,13) (113,18) (113,63) (113,513) 
Specificity ([D+F]/[B+D+F]) 1.00 1.00 1.00 1.00 
    Beta distribution (D+F, B) (119873,1) (119868,1) (119823,1) (119373,1) 
a Children residing in Philadelphia County, PA, aged birth through six years; estimated from the 2010 U.S. 
Census. 
b Re-classified per the 2014 Council of State and Territorial Epidemiologists pertussis case definition. 
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Table 23. Naïve and Bayesian corrected measures of pertussis DTaP vaccine 
effectiveness for varying degrees of underreporting of true cases. 
Analysis and Outcome Measure VEa,b 95% CI/CrI 95% CI/CrI Ratio 
Naïve    
    Imperfect apparent 50% (16%, 69%) 4.3 
Bayesian correction    
    No underreporting 57% (30%, 73%) 2.4 
    5 true cases not reported 58% (31%, 74%) 2.4 
    50 true cases not reported 61% (33%, 78%) 2.4 
    500 true cases not reported 82% (43%, 95%) 2.2 
VE, vaccine effectiveness (=[1 – OR]*100). 
a Adjusted for child age, child race, and maternal parity. 
b Figures correspond to the mean of the posterior distribution. 
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Table 24. Posterior mean sensitivities, specificities and 95% credible intervals for 
classification of pertussis for varying degrees of underreporting of true cases. 
Analysis Posterior SN Posterior SP 
No underreporting 89.5 (83.7, 94.3)a 100 (100, 100) 
5 true cases not reported 86.0 (79.5, 91.4) 100 (100, 100) 
50 true cases not reported 63.7 (56.2, 70,7) 100 (100, 100) 
500 true cases not reported 18.4 (15.9, 21.0) 100 (100, 100) 
SN, sensitivity; SP, specificity. 
a Estimates are given as percentages (95% credible interval). 
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Figure 11. Conceptual diagram of etiologic pathway. 
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Figure 12. Misclassification of pertussis case definition applied to the population of 
children in Philadelphia, PA (a.) and derivation of case definition sensitivity and 
specificity (b.). 
a. 
 
b. 
 
Reported cases = A + B + C + D 
Health Department cases = A + B 
True cases = A + C + E 
Study controls = B + D + F 
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Figure 13. Posterior distribution (a.) and model diagnostics (b.) of β1 (UTD) 
assuming no underreporting of true cases (E=0). 
a. 
 
b. 
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Figure 14. Posterior distribution (a.) and model diagnostics (b.) of β1 (UTD) 
assuming 5 true cases not reported (E=5). 
a. 
 
b. 
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Figure 15. Posterior distribution (a.) and model diagnostics (b.) of β1 (UTD 
assuming 50 true cases not reported (E=50). 
a. 
 
b. 
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Figure 16. Posterior distribution (a.) and model diagnostics (b.) of β1 (UTD 
assuming 500 true cases not reported (E=500). 
a. 
 
b. 
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5. DISCUSSION and RECOMMENDATIONS 
5.1. Summary of Findings 
Our principal findings in this dissertation are as follows. 
For the first aim, we demonstrated that pediatric pertussis incidence is non-
randomly reported in Philadelphia. There are specific neighborhoods that have an 
increased risk of pertussis, solely based on the neighborhood where the child resides. 
Further, the density of day cares in that neighborhood was unrelated to the risk of 
pertussis. 
For the second aim, we considered various measures of vaccination coverage in 
vaccine effectiveness studies and found that the traditional measure of up-to-date on 
pertussis-antigen containing vaccines may not be the best measure in terms of etiologic 
regression modeling. By examining the number of doses received, we were able to better 
describe the risk of pertussis, independent of a child’s up-to-date status. 
For the third aim, we observed meaningful misclassification of pertussis, that 
when corrected, strengthened the vaccine effectiveness. Likewise, when accounting for 
underreporting of the disease, there was a similar strengthening of the vaccine 
effectiveness. This misclassification was due to two primary factors: 1) the change in the 
case definition for 2014 to incorporate infant apnea as an additional diagnostic criteria, 
and 2) hypothesized underreporting of pertussis. Sensitivity of the case definition was 
variable depending on the amount of underreporting, where less underreporting resulted 
in improved sensitivity. Specificity was overall high indicating few cases that are 
incorrectly classified as pertussis. 
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For all aims, we noted strong evidence that the Diphtheria, Tetanus, and acellular 
Pertussis vaccine confers protection against reported cases of the disease. 
 
5.2. Limitations and Strengths 
There are several potential limitations to this research. First, reporting of pertussis 
in Philadelphia is a passive system that captures only confirmed and probable cases, 
resulting in an underestimation in the number of cases. Second, the case-definition for 
pertussis has changed over time, which may result in misclassification. Through our third 
aim, we were able to model the uncertainty of underreporting and a changing case 
definition through Bayesian misclassification correction. Third, due to the time periods 
examined in this study, there may be population migrations. For example, if families 
were likely to in-migrate because of availability of vaccine, and these children were at 
higher risk for pertussis, vaccine effectiveness could be underestimated. Fourth, as 
vaccination data is derived from the citywide IIS, the records are subject to the same 
limitations that any IIS is subject to, namely the records are incorrect or incomplete.137 
Based on the experience of the PDPH, KIDS Plus IIS captures the majority of 
vaccinations and is regularly validated by nursing staff who visit clinics to ensure 
vaccination records are complete. Fifth, in the first aim, the primary exposure of day 
cares may be subject to misclassification by several mechanisms including 1) the 
Pennsylvania DPW not capturing unregistered day cares, 2) day cares changing over 
time, and 3) the day care in the clustering unit not serving the community in that area. For 
example, we may underestimate the magnitude of effect if there were more pertussis 
cases in neighborhoods with more unregistered day cares, perhaps due to less stringent 
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(or nonexistent) vaccination requirements. Sixth, in the second aim, while the goal of this 
study was to guide other researchers in their choice of a vaccination uptake measure, the 
results may be specific to pertussis in Philadelphia, although every effort was made to 
guard against a selection bias that could affect generalizability. Seventh, in the third aim, 
we assumed proper prior specification in the Bayesian analysis, including perfect 
classification of the covariates and exposure. Priors may have strong influence on the 
posterior distributions, and if the validation study does not accurately represent the same 
population, may bias the present analysis. Adding statistical uncertainty to the prior 
(increasing the variance) can help mitigate this occurrence. 
There are many strengths to this research. First, the use of the city-wide 
immunization information system allowed us to sample from a representative population. 
Therefore, the results should be generalizable to other cities. Second, we had a large 
sample size and were adequately powered to detect differences, should they exist. Third, 
overall missing data was minimal. Fourth, detailed vaccination histories allowed us to 
classify vaccination status using several measures. Fifth, use of a Bayesian framework 
that readily allowed flexible incorporation of useful prior knowledge including 
unreported cases. 
 
5.3. Public Health Significance 
This work informed the Philadelphia Department of Public Health and public health 
community by: 
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1. Demonstrating that pertussis may be distributed differentially throughout the city 
neighborhoods, and determinants of disease occur primarily at the familial and 
individual level. 
2. Demonstrating that in vaccine effectiveness studies, researchers may want to 
consider the number of doses as the primary risk factor for pertussis diagnosis, as 
opposed to the traditional measure of being up-to-date on pertussis-antigen 
containing vaccines. 
3. Showing research that uses historic data should consider case classifying the 
entire population according to the most recent case definition, as well as account 
for underreporting, to arrive at better estimates of vaccine effectiveness. 
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6. APPENDICES 
6.1. Appendix A: Vaccination Schedules 
The following figure depicts the 2013 CDC/ACIP recommended vaccination 
schedule for children aged 0 – 18 years of age. 
 
Figure 17. 2013 CDC/ACIP childhood recommend immunization schedule. 
 
Figure reprinted from ACIP Childhood/Adolescent Immunization Work Group et al., 201313 
 
This schedule can be modified depending on whether a particular child has missed 
a dose or was delayed starting, known as “catch-up” vaccination, and modified for 
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special populations, including high-risk conditions, such as a compromised immune 
system. 
In addition to the above CDC/ACIP schedule, there are alternate and reduced 
vaccine schedules. Drs. Robert Sears and Stephanie Cave have proposed two of the 
better-known alternate schedules. 
 
Table 25. Dr. Robert Sears's alternate vaccine schedule. 
Age Vaccines 
2 months DTaP, Rotavirus 
3 months* PCV, Hib 
4 months DTaP, Rotavirus 
5 months* PCV, Hib 
6 months DTaP, Rotavirus 
7 months* PCV, Hib 
9 months IPV, Influenza* 
12 months Mumps, IPV 
15 months PCV, Hib 
18 months DTaP, Varicella 
21 months* Influenza 
2 years Rubella, IPV 
2 years, 6 months* Hep B*, Hep A 
3 years Hep B, Measles, Influenza* 
3 years, 6 months* Hep B, Hep A 
4 years DTaP, IPV, Influenza* 
5 years MMR*, Influenza* 
6 years Varicella 
12 years Tdap, HPV 
12 years, 2 months* HPV 
13 years HPV, Meningococcal* 
Adapted from Sears 200714; *see explanatory notes on pgs. 236 & 237. 
 
Table 26. Dr. Stephanie Cave's recommended vaccine schedule. 
Age Vaccines 
Birth Hep B* 
4 months Hib, IPV 
5 months DTaP 
6 months Hib, IPV 
7 months DTaP 
8 months Hib 
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9 months DTaP 
15 months Measles 
17 months Hib, IPV 
18 months DTaP 
21 months Rubella 
24 months PCV 
27 months Mumps 
4-5 years DTaP, IPV 
4-5 years Hep A* 
4-5 years MMR* 
5-12 years Hep B* 
12 years Varicella* 
12 years Tdap* 
College dorm Meningococcal 
Adapted from Cave 201015; *see explanatory notes on pg. 311. 
 
As can be seen in these tables, there are many more doctors visits required 
following the alternate schedules, as fewer vaccinations are given at any one time. 
Robinson and colleagues attempted to quantify the frequency of “shot-limiters,” where no 
more than two shots are given at a specific visit, in a retrospective cohort of children aged 
nine months or younger in metropolitan Portland, Oregon.138 They found less than 5% of 
included children met the criteria for a shot-limiter, with a minority of them actually 
adhering to an alternate schedule, but the trend was increasing over time. The authors did 
not enumerate specific characteristics of people opting to adopt alternate schedules, a 
potentially useful exercise to inform public health authorities of characteristics to shot-
limiters. 
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6.2. Appendix B: Vaccination Exemptions 
The constitutionality of mandated vaccination in the U.S. was established in the 
1905 Supreme Court case Jacobson v. Massachusetts, which ruled that the common good 
allowed a state to require vaccination.139 Since this time, many states have amended the 
vaccination laws to allow for exemptions. Although a complete discussion of the tension 
between public health and personal liberty is outside the scope of this work, there are 
several reasons why an individual (or group) may abstain from vaccination, thereby 
influencing the vaccination coverage and consequently an individual or group 
susceptibility to disease. The College of Physicians of Philadelphia defines three 
categories of exemptions: 1) medical, 2) religious, and 3) personal belief.140 
Medical exemptions to vaccination include medical contraindications or 
precautions that have a physiologically known mechanism where administration of a 
specific vaccine can have harmful or even fatal adverse effects. For example, most 
influenza vaccines are contraindicated to individuals with severe allergies to egg 
proteins.7 As the flu viruses are grown in chicken eggs, vaccination can cause a 
potentially life threatening reaction for those with egg allergies. All 50 states in the U.S. 
allow medical exemptions to vaccination, while Mississippi and West Virginia allow only 
medical exemptions. Spurious medical associations that have not been scientifically 
proven (e.g., the purported link between thimerosal and autism) fall under personal belief 
exemptions. 
Religious exemptions are allowed in 48 states and depending on the specific state 
laws, may require documented proof of belonging to a religious group that objects to 
vaccination.140 Reports in both popular press and scientific peer reviewed literature 
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associate certain religious congregations to vaccination uptake and disease occurrence. 
For example, a 2013 outbreak of measles in a community in Texas was tied to a 
congregation that had a high proportion of unvaccinated individuals.23 The pastor’s belief 
that vaccination can cause autism may have led to this view within the congregation, and 
subsequently the refusal to get vaccinated. An ecological study conducted in the 
Netherlands “Bible belt” demonstrated that regions with orthodox protestant 
denominations had lower vaccination coverage and were at an increased risk for 
community disease.86 Clearly, religion is a powerful and sensitive motivator in health. 
Personal belief exemptions are currently allowed in 20 states and essentially catch 
all other arguments that a parent or individual might have against vaccination, including 
alleged associations that have received widespread attention. For example, the 
preservative thimerosal previously used in several vaccines, including the childhood 
MMR series, was purported to cause autism. Studies have consistently shown no 
demonstrated association between thimerosal and autism.141,142,143 Despite the dramatic 
and often negative attention vaccine safety issues engender, scientific studies analyzing 
vaccination are nonetheless worthwhile endeavors. A negative finding (e.g., thimerosal 
and autism) can be just as powerful as a positive finding (e.g., the rotavirus vaccine 
RotaShield that was pulled from market due to risk of intussusception). As with religion, 
personal beliefs are also of crucial importance in health, and can be studied by proxy 
through behaviors like abstaining or limiting vaccination to use of an alternate 
vaccination schedule (see Appendix A: Vaccination Schedules). 
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6.3. Appendix C: PDPH Notifiable Disease Case Report 
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6.4. Appendix D: PDPH Pertussis Investigation Form 
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6.5. Appendix E: Philadelphia Neighborhoods by Census Tract 
 Neighborhood Census Tracts 
1.  Bustleton  344-345, 355-356 
2.  Center City  1-12, 366 
3.  Chestnut Hill-W. Mt. Airy  224-237, 239, 257 
4.  Cobbs Creek  80-85 
5.  East Falls-Westside  206-208, 240, 243-244 
6.  East Mt. Airy  250-256 
7.  Eastwick-Elmwood  54-62, 67-68 
8.  Fairmount-Spring Garden  125, 133-136 
9.  Frankford  293-296, 299-302 
10.  Germantown  238, 241-242, 245-249 
11.  Grays Ferry-Passyunk  33-36, 46-48, 50-51 
12.  Haddington-Overbrook  93-96, 100-102, 112-115 
13.  Hunting Park-Fairhill  174-176, 194-199 
14.  Juniata Park-Harrowgate  187-193 
15.  Lawndale-Crescentville  291, 292, 303-307, 367 
16.  Logan  280-284 
17.  Lower Kensington  143, 158-161 
18.  Mayfair-Holmesburg  315-318, 329-333 
19.  Mill Creek-Parkside  92, 103-111, 124 
20.  Nicetown-Tioga  170-173, 200-205 
21.  Northern Liberties-West Kensington  126-130, 142, 144, 156-157, 162-164 
22.  Oak Lane-Fernrock  268-272, 276 
23.  Ogontz  265, 267, 277-279 
24.  Olney-Feltonville  273-275, 285-290 
25.  Overbrook Park-Wynnefield Heights  97-99, 116-123 
26.  Oxford Circle  308-314 
27.  Paschall-Kingsessing  63-66, 69-75 
28.  Pennsport- Queen Village  15-18, 25-27 
29.  Poplar-Temple  131, 132, 141, 145, 146, 154, 155, 165, 166 
30.  Rhawnhurst-Fox Chase  334-343 
31.  Richmond-Bridesburg  180-186 
32.  Roxborough-Manayunk  209-222 
33.  Schuylkill-Point Breeze  13, 14, 19-22, 31, 32 
34.  Sharswood-Stanton  138-140, 147, 148, 153, 167 
35.  Snyder-Whitman  41, 42, 44 
36.  Somerton  357-360, 365 
37.  Southwark-Bella Vista  23, 24, 28-30 
38.  South Broad-Girard Estates  37-40, 45 
39.  Strawberry Mansion  137, 149, 151, 152, 168, 169 
40.  Torresdale-North  353, 354, 361-364 
41.  Torresdale-S.-Pennypack Park  328, 346-349, 351, 352 
42.  University City  76-79, 86-91 
43.  Upper Kensington  177-179 
44.  West Oak Lane-Cedarbrook  258-264, 266 
45.  Wissinoming-Tacony  297-298, 319-327 
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Adapted from PDPH 2006100; Census tracts defined per year 2000 census divisions. 
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6.6. Appendix G: BUGS Model Specification for Bayesian Inference via JAGS in R 
model { 
    for (i in 1:n) { 
     
      #outcome model, log odds of pertussis given these predictors 
      case[i] ~ dbern(p_case[i]) 
      logit(p_case[i]) <- b0+b1*utd[i]+b2*age[i]+b3*race[i]+b4*multiparous[i] 
       
      #exposure models, log odds of utd given these predictors 
      utd[i] ~ dbern(p_utd[i]) 
      logit(p_utd[i]) <- a0+a2*age[i]+a3*race[i]+a4*multiparous[i] 
       
      #measurement model, imputing the true case status given the measurement error 
      case_star[i] ~ dbern(p_case_star[i]) 
      p_case_star[i] <- sn0*case[i]+(1-case[i])*(1-sp0) 
       
      #prevalence models of potential confounders 
      age[i] ~ dbern(p_age[i]) 
      logit(p_age[i]) <- prev_age 
       
      race[i] ~ dbern(p_race[i]) 
      logit(p_race[i]) <- prev_race 
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      multiparous[i] ~ dbern(p_multiparous[i]) 
      logit(p_multiparous[i]) <- prev_multiparous 
     
    } 
     
    #priors 
    #for normal distribution, provide (mean, precision=(1/variance)) 
    #for beta distribution, provide (alpha, beta), add beta(1,1) 
     
    b0 ~ dnorm(0,1/10) 
    #b1 ~ dnorm(-1.77,1/0.002) 
    b1 ~ dnorm(-1.77,1/0.5) 
    b2 ~ dnorm(0,1/10) 
    b3 ~ dnorm(0,1/10) 
    b4 ~ dnorm(0,1/10) 
    a0 ~ dnorm(0,1/10) 
    a2 ~ dnorm(0,1/10) 
    a3 ~ dnorm(0,1/10) 
    a4 ~ dnorm(0,1/10) 
    prev_age ~ dnorm(0,1/10) 
    prev_race ~ dnorm(0,1/10) 
    prev_multiparous ~ dnorm(0,1/10) 
    #sn0 ~ dbeta(113,13) #E=0 
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    #sp0 ~ dbeta(119873,1) #E=0 
    #sn0 ~ dbeta(113,18) #E=5 
    #sp0 ~ dbeta(119868,1) #E=5 
    #sn0 ~ dbeta(113,63) #E=50 
    #sp0 ~ dbeta(119823,1) #E=50 
    sn0 ~ dbeta(113,513) #E=500 
    sp0 ~ dbeta(119373,1) #E=500 
}  
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